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ABSTRACT 
A MULTI MODALITY DRUG ABUSE TREATMENT PROGRAM 
FOR HIGH ECONOMIC-STATUS PATIENTS 
Dav id M. Dc kert 
This study was a pre-post, s1ngle group evaluation of a 
drug-abuse treatment program at a pr1vate psychiatr1c hospital 
located in the north eastern United States. 
Subjects consisted of 101 consecutive atypical patient 
adm1ssions. They were predominantly white male professionals 
in their late twenties who earned almost $45,000 per year and 
had about two years of college. 
The data-base included patient information obtained using: 
The Addiction Severity Index (ASI), The Brief Psychiatric 
Rating Scale, The Beck Depression Scale, drug history 
variables and a natural support systems matrix.· 
Seventy-four of the patients successfully·completed the 
inpatient treatment protocol, 26 did not and 1 died. Subsequent-
ly, 51 entered the outpatient program. 
Telephone followups on the patients were carried out 3.5 
months post discharge from the inpatient program; on these inter-
views the ASI was administered. At these follo\'A.Ips 51 subjects 
were found to be readdicted, 46 were drug free and data for 4 
were unobta ina bl e. 
The relationships of social, psychological and biochemical 
factors to occurrence and severity of drug use at post-treatment 
fo 11 owu ps were exam i ned • 
The analytiC strategy employed chi square, correlation, 
hierarchical multiple regression. and residualized change score 
analyses. 
The results indicated that the longer a patient remained in 
treatment the more likely he was to be drug free at follow.ap. 
espeCially if the patient entered the outpatient program. 
Antecedent factors predicting longer length of stay in 
treatment were 1) strong economic support status and 2) the 
existence of a supportive conjugal dyad. 
Two other antecedent factors were directly related to inc i-
dence of readdiction and its severity at followup. First, the 
greater the degree of pre-treatment legal involvement the greater the 
probability and severity of post-treatment readdiction. Second, 
the type of pre-induction drug of abuse predicted post-treatment 
readdiction and severity--methadone being the greatest predictor 
followed in order by "speedball" (a mixture of heroin and cocaine). 
heroin and cocaine. Additionally. it was found that the subjects 
taking psychotropiC medication during the inpatient and continuing 
into outpatient phase of treatment were the most likely to be 
drug-free at followup. especially for the high psychiatriC severity 
patients. 
The total pattern of results indicate that a social. 
psychological and biochemical treatment strategy is necessary 
to---fulf-i-ll--the- treatment needs- of d'rug-ablfse- p-atie.i'it-s-. -------
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DEFINITION OF RELEVANT TERMS 
Opioid Analgesics 
Opioids are meant as any dr.ug. regard.less of chemical structure. 
that act 11 ke morphine. These include: heroin (d iacetylmorphine.); 
oxycodone (percodan); methad·one.· <'prinadol); d.-propoxypbene (darv·on); 
codeine (methylmorphine); hydromOrpbone (d·n audid); oX}1Tlorpbone. 
(numorpban). Tbese may 6e administered by intravenous. oral. nasal. 
or su bcutaneous methods. 
The Opioid Antagonist 
In brief, Naltrexone antagoriizes or prevents morphine (opioi.d.) 
produced narcosis, analgesic test responses. and respiratory 
depression (Wikler, 1980). Essentially, this means that an individual 
on a singl e 50 mg. dose of Nal trexone will have no eupboric effects 
from subsequent administration of a morphine-like substance. 
Naltrexone blocks the effects of opioids and is considered a "pure" 
opioid antagoni st, devoid of ·opioid-li ke agonistic actions (Blumb~rg 
and Dayton, 1972). 
Clonidine Hydrochloride 
Clon·idine hydrochloride is a non-opioid detoxification 
substance that is reported to su.ppress the S}1Tlptoms of opioi.d with-




The goal of this study is to evaluate a drug abuse 
treatment program in a private psychiatric hospital located. in a 
north eastern suburban community. The drug abuse treatment 
program uses multiple treatment modalities, both psycho-social 
and biochemical, employing staff social workers, psychiatrists, 
psychologists, ex-addict drug counselors, psychiatric nurses, and 
medical internists. 
Unlike many drug abuse treatment programs, this 
program's patient population is dominated by affluent and 
1 
upwardly mobil e men. During the period of thi s study from February 
1982 to December 1982, the typical patient accepted for treatment 
of drug abuse was a white male professional in his late twenties, 
with approximately two years of college, earning almost $45,000 per 
year. In addition the treatment program is expensive--a semi-
private room in 1982 cost $6,000 per week. In February 1982 the 
total patient population was 160 of which 45 were registered for 
treatment of drug-arose. 
This treatment program merits attention for a number of reasons. 
First. the study population--those patients undergoing treatment for 
drug abuse during the period of this study--has received scant 
attention in the annals of drug abuse treatment literature. With 
rare exceptions, the literature focuses on tbe poor and under-
- -------- - - -- -pr-iv-il-eged-. -t-ha-t- -is, ur ba'n dr,ug abusers who' bec'ause-of-------- -
poverty must seek treatment within publicly funded 
programs. 
Second, the wide variety of resources used in the 
program and the responsiveness of po1icymakers there to on-going 
problems created an environment that was rich in the variety of 
treatment modalities offered in the drug abuse program. These 
conditions, in fact, were the antitbesis of the assembly-line 
treatment and bureaucratic red tape all too often associated with 
pu b1ic1y funded drug abuse treatment programs. 
Costs of Drug Addiction 
The need for more effective drug abuse .treatment programs 
is not difficult to appreciate. Statistics from the National 
Institute of Drug Abuse (NIDA) indicate that in 1982 the cost 
of all drug abuse treatment programs in the United States 
amounted to $500 million (NIDA, 1982). One,must also bear in 
mind the enormous amounts spent on law enforcement by the 
federal Drug Enforcement Administration ($280 million, 1982)* 
and additionally the manpower (and the money it represents) 
directed aga inst drug trafficking by state and local governments. 
*Te1ephone Communications with DEA representative, August 1983. 
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In addition to the high monetarj costs, the social costs of 
drug abuse are incaluable--individual lives are destroyed, families 
are broken up, and the emergence of the illegal drug distribution 
system that is associated with dr.ug abuse. In a quarterly report 
NIDA indicates that only 23 ·percent of the. patients in state and 
federally funded drug abuse treatment programs compl eted their 
treatment. Of these patients only 16 percent were reported to have 
had no drug use during the month preceding discharge (NIDA, 1979). 
Clearly, then, the need for more effective drug abuse treatment 
programs is obvious and unequivocal. 
The Research Environment 
The hospital accepted voluntary patients only, excluding 
those who were deemed potentially violent or otherwise medically 
unstable, that is, those who were in potentially life-threatening 
situations. In general t the treatment program for drug abusers 
lasted a total of eight weeks with each patient making a commitment to 
canplete the program as a condition of admittance. Hospital fees, as 
stated previously, amounted to $6,000 per week and were paid for 
primarily by private insurance plans held by the patient's employer 
and/or family. 
During the period covered by this study, from February 1982 to 
December 1982, the hospital's total drug abuse patient population 
averaged 45 patients in a given week. As noted before, 101 patients 
being treated for drug arose were included in the present study. The 
hospital treated apprOXimately 200 patients per year in its program for 
drug abusers which had been in operation for three years prior to 1982. 
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The hospital complex totaled. ~ive buildi.ngs, four of whtch 
were used for patient care; the other b.dld:ing c.ontai.ned· admi.nistrative 
.. 
offices and impressive laboratories with state-of-the-art equi.pment. 
Two of the patient-care buildi.ngs.·were older and two newer. The two 
older buildings were th.e or.iginal .hospital building, constructed in 
the 1 ate 70 IS, and a 1 arge Victorian-styl e house used for recreati.onal 
and group therapy meetings. 
Of the newer bu il dings, one. had been opened within the past five 
years and was quite spacious with, for example, lots of windows. The 
second newer building was, at t.he time of this study, under construc-
tion and opened in 1983. 
It should be emphasized that a very high stand·ard of cl eanl iness 
was maintained throughout, and that the equipment and facilities were 
of the quality expected of a first-class research hospital (although 
this hospital was not a medical-school affiliate). The equipment and 
facil ities were enhanced by elegant furniture in the recepti.on areas 
and by modern paintings which hu.ng throughout the hospi.tal complex. 
Professional staff members included 12 social workers, 6 psycho-
logists, 15 psychiatrists, 8 ex-add.ict drug counselors, 4 psychiatric 
nurses, and about 5 medical internists. Key supervisory personnel 
included an M.D. research director, an M.D. drug-unit director, and 
an exaddict drug-unit supervisor. 
Overview of Treatment Program 
Upon entry to the hospital, each drug-abuse patient began 
the hospital IS three-stage treatment program. 
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During the period of this study, the hospital was controlled_ 
by a group of young doctors with a keen interest in developing innova-
tive approaches to drug abuse treatment. The primary treatment goal, 
of course, was drug free status. The psyc~social treatment 
objectives were to encourage patfents toward acceptable resocial1zatfon. 
This was achieved by using an in-patfent treatment approach aimed at 
socially structured limit setting, and cooperative living arrangements 
geared toward the development of motivation for successful detoxifica-
tion and eventual drug-free outpatfent status. There was emphasis on 
reentry and adaptation to the conununity, using medical and psychosocial 
support. 
The medical objective was to detoxify and stabilize each patient, 
a necessary part in achieving a drug-free existence. 
The three treatment stages were: 
In-Patient 
a. Evaluation, detoxification and stab1lization unit. 
b. Drug-free unit. 
Outpat ient 
c. Community reentry. 
The evaluation and stabilization stage took place during the first 
two weeks of in-patient status. The evaluation consisted of: 
a. Family and psychosocial evaluation by a social worker. 
b. Determining the type of drug or drugs abused and drug-use 
level(s) by the M.D. medical staff. 
c. Eliciting demographic information by -a psychiatric nurse. 
d. Psychiatric and psychological status as determined by the 
Brief Psychiatric Inventory and. the Beck depression 
scale admi.nistered by a psychiatri.st. 
e. Medical evaluation by the:M~D. medical staff. 
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While in the evaluation stage th.e patients were seen dai.ly by a 
physician, who assessed vital s.igns includi.ng blood pressure. During 
this stage, the patient also was'seen by an ex-addict counselor. 
During the detoxification stage clonid.ine hydrochloride. was used 
when appropriate for all opioid. aoose patients (Washton, Resnick and 
Rawson, 1979). The starting d:ose of C16nid ine was 1.7 micrograms-per-
mi 11 igram shifti ng to a dose protocol regiment as needed (PRN). 
During this stage patients and their families began family group 
meetings with a social worker as group lead:er. In addition the patients 
attended a drug group meeting five days a week with an ex-addict drug 
counselor, a social worker, anda psychiatric nurse. The various meet-
ings lasted, on the average, from one to two hours as needed. During 
the detoxification stage the patients saw an M.D. three ti.mes per 
week for med ical evaluation arid most pati ents began da ily exerci.se 
and g}111-participation requirements led. by a recreational therapist. 
During the drug free stage patients saw a psychologist one to three 
times per week and sexual-dysfunction group therapy also began in 
detoxification, if needed. 
The community reentry stage included multiple-family group 
meetings led by a SOCial worker, individual family therapy with a 
social worker, and psychothe.rapy. one to three times per week with a 
Ph.D. psychologist. 
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Study Design and Theoretical Frame~rk 
The hospital setting offered a further inducement for 
study of its drug-abuse treatment pr,ogram in add Uion to a se1 ect 
patient population, a high staff-to-patient ratio, multi-faceted treat-
ment strategy, and modern facilities and~ equipment--the hospital staff 
carried on extensive bio-chemica1 research and, thus, this facility 
could properly be classified as a research hospital (see above, page 
4, for a description of its laboratories). The h'ospital 
env ironment was, therefore, a highly refined mil ieu in whi,ch to 
address the central question of this study: how effective was the 
drug-abuse treatment program at the hospital. 
To aid in answering this question, the study design was divided 
into three parts: premeasurement, treatment process data and disc harge 
status, and the post-rneasurement (see Chapte~ II, "Methodo1 ogy, II for 
more detailed information). In shaping the study design, one was 
keenly aware that the available evidence suggested a variety of treat-
ment interventions and modalities were not only possible but also 
eff'icacious. However, it remains difficult to compare different drug 
abuse treatment programs for this very reason, that is, the varying 
evaluation and treatment methodologies often work against establishing 
a reliable basis of comparison (see Chapter 11, pp. 15 and 22). 
Nevertheless, assumptions regarding drug abuse treatment programs, 
and the patients in these programs, can be made. , 
Pre-treatment. First, the pre-treatment status of drug abusers' 
is, of course, a salient factor. Kleinman and Lukoff (1980) identified 
two critical periods in, the lives of addicts; periods which they 
8 
_ believe are crucial to predicting drug abuse treatment outcome. 
The first pre-treatment period involves the variables of employ-
---- --. _. --------------------- - -.--- - --_ .. 
-------- -- -- -- ment -statuS:-- crime rate, and marital status variabl es at entry that 
affect outcome. The second period occurs in late adolescence and the 
variables are age of addiction, age of first arrest and years of 
education compl eted. 
Lu koff (1974) found that those with arrests preced ing the onset 
of their drug arose tended to persist in criminal behavior. In 
addition, youthful onset of regular drug use is associated with higher 
rates of criminality, less education, and poor employment history than 
those who began their drug use later in life. The data suggested that 
- . 
the younger the age. at which drug use or crime began, the more prone 
these subjects were to increas~d deviance in general (Lukoff, 1974). 
Earlier onset of drug use or criminal behavior was related to proportion-
ately less employment, education, and marriage. 
Lukoff in fact has suggested that early onset of either deviant 
behavior pattern may constitute a truncated socialization, resulting 
in a less developed ability to cooperate with a treatment protocol. 
Specifically, earlier onset of drug use or crime generally resulted in 
a shorter stay in treatment and a pOQr prognosis' for 'positive' treatment 
outcane. In other words, the earl ier age of first treatment conta.ct, 
the earlier the age of onset of regular drug use.and the earlier the 
age of first arrest were indicators of an earlier truncated socialization, 
thereby producing less successful treatment outcomes. One of the assump-
tions made regarding the present study was that the earlier the age of 
first arrest, the less likely the patient was to complete a drug abuse 
treatment program. 
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Treatment. The drug abuse treatment program util ized 
in-patient professional treatment and in-patient self-help groups that 
resembles family relations. In-patient status required the addicts 
to live together on a twenty-four hour basis in a family-like tie. 
Additionally, there was great emphasis on the mobilization of primary-
group support networks in order to prepare the patients for re-entry 
into the community and encourage participation in the outpatient 
phase of the treatment protocol. 
The developnent of adverse physical symptoms (common in detoxifi-
cation) which impede everyday living often made it difficult for anyone 
to 1 ive with a patient. When the detoxification phase of treatment was 
successfully completed, one could readily recognize that there were 
everyday forms of temporary mental stress requiring non-uniform tasks 
which experts were not available to handle. 
l1tWl k (1978) suggested that opt imum mental hea 1 th care is 
produced when patients have access to reliable non-experts who aid in 
assuaging minor sources of anxiety while also having access to profes-
sional experts and institutions for enduring anxiety problems. 
Resnick (1979) and others have proposed that the incentive for 
seeking and using opioids for some addicts is due to physical or 
emotional distress of a magnitude comparable to psychiatriC s.Yl11ptoms. 
If the addict is "self-medicating" his psychiatric s.Yl11ptoms, that is, 
abusing drugs in -order to rel ieve the symptoms, then one way to .remove 
the incentive for seeking and using opioids is to remove the s.Yl11ptoms. 
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Another assumption of the present study was that the more 
resources the patient could draw upon--for example, fellow.patients, 
---' ------.--- -'-' - '--TanilTY-and- friends, job skills--the qreater--th-e-ffi<ei ihood that the----··- - --.----
patient would succeSSfully complete the drug abuse treatment program. 
Yet another part of the treatment program NaS the use of psycho-
tropic drugs. Drug. therapy for treatment of drug abu se rena ins 
controversial; many professiona 1s ,look upon drug therapy as merely 
transferring dependence from one drug to another. 
Drug therapy at the oospital, then, deserves particularly 
close scrutiny, presented later in the study (see Chapter 4, page 97). 
The treatment strategy at the hospital called for the use 
of Clonidine, a nonopioid medication, during detoxification followed, 
when appropriate, by the prescription of psychotropic drugs. Clonidine 
significantly reduced the' discomfort associated with withdrawal from 
drug abuse, but did not induce euphoria (Gold et al, 1980). 
Yet another assumption of this study was that Clonidine could 
prove useful in forecasting how well patients would perform during the 
follow-up of this study. It' is assumed that higher doses of opioids 
at intake produce poorer follow-up outcomes. In this instance high 
doses of Clonidine may iridicate higher preinduction doses of opioids. 
Outpat ient treatment~ Foll ow-up researc h has long constituted a 
knotty problem in evaluation research. An additional assumption of 
this study: a patient who was drug free at a follow-up enjoyed a more 
stable 1 iving environment than a patient who had become readdicted. 
In The Psychiatrically Severe Drug Abuse Patient, McLellan,' et 
al. (l982), examined the effects of pre-treatment psychiatric status 
11 
and treatment mod al tty on response to drug abuse rehabil itation. 
Improvement at six months was measured by three criteria--drug use. 
emplo.)1llent, and criminal ity. In bo~h the Therapeutic Commu.nity (TC) 
and Methadone Maintenance·{MM) pr.ograms, all measures showed a direct 
relation between treatment duration and improvement. Tbe data 
indicated that when the treatment group was divided between low. 
mid, and high psychiatric severity grou.ps (as detennined by the 
ASI) the high-severity group generally had the 1 east improvement 
in outcome criteria. In contrast, the low and mid-severity groups 
reported greater improvements at the six-rnonth follow-up (Mclellan, 
et a 1. 198 2) • 
If the high psychiatric severity group were "sel f-rned 1cators" 
following (Resnick, 1979). then those patients who experienced 
significant psychiatric s.)1llptomology may bec~me add icted 1 a.rgel y 
due to the s.)1llptom-reduction effects of illegal non-prescription 
drugs. According to Resnick this group generally had less 
favorable follow-up outcomes. Self-medicators may be at a higher 
risk of impulsive readdiction than nonself-rnedicators during 
the critical community reentry period. The drug abuse treatment 
strategy included stringent controls and a great deal of support 
from the staff and other drug abuse patients. ·Although the 
outpatient reentry program offered individual and group psycho-
SOCial supports. this may not have been enough for the self-
medicators. Resnick in referring to the conditioned-abstinence 
12 
hypothesis (see Chapter 2, page 21), stated that in addition to 
-psycho-soc ia 1 su pport, sel f-med icat i n9 patients may need biochemical 
-su-ppor-t-for--successful outcomes ~ - - --------- ----- ------------
One may speculate that without biochemical support (in addition. 
of course, to psychosocial support) there could be a greater 1 ikel ihood 
of the patient. during a period of increased emotional labil ity, to 
impulsively use illegal nonprescription drugs for their symptom-
reduction effects and become readdicted. 
Conclusion 
Treatment for drug addiction remains a matter of consider-
abl e discussion and controversy. Treatment programs and eva 1 uat ion 
methods vary widely. A range of treatment modalities, -and the setting 
in which they are administered, has been outlined in Chapter I. In 
Chapter II, "literature," a full er exploration of the rel evant writing 
on the su bjec t will be conducted. 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
The literature survey will begin with an historical review of 
the various treatment rationales for opiate abuse and the existing 
evidence for efficacy of the various treatment modalities. An approach 
of this nature is appropriate because of the effect these rationales 
and treatment outcomes have had on the course of opioid abuse, treat-
ment, and research. Reference to the epidemiological literature 
will be used to shed light on the development of current treatment 
strategies and treatment evaluation methods. 
Prior to the Harrison Act of 1914, legal access to opiates was 
relatively unrestricted and they were available without a dov,or's 
prescription. Following passage of this act., phYSicians resorted to 
the only treatment legally available for drug addiction, that of 
opiate maintenance. However, physician prescription of opiates was 
almost immediately. halted by legal pressures (Terry and Pe111ns, 1928). 
The subsequent development of an illegal drug-distribution system, 
coupled with the rising cost of heroin and a quickly developed 
tolerance, were thought to drive the so-called opiate-hungry addict 
to steal in order to support his habit. Therefore, in the 1920's, 
local health boards introduced morphine-maintenance clinics in order 
to deal with the assumed criminal connection of addicts. These 
maintenance programs, however, were closed by 1924 due to patient 




Treatment of opiate dependence did not again exist in institu-
---t-iona-l -formunt i1 1935 -f-n-response to -th-e--groWi'r'lg num6er -of -opiate--------
addicts in federal prisons. Federal prison hospitals were established 
during that year within the federal prisons at Lexington s Kentucky 
and Fort Worth, Texas; their purpose htlS to isolate criminal add icts 
from the rest of the prison population and treat them in a drug-free 
environment which stressed opioid (methadone) detoxification. 
Patients at the two prison hospitals formed the first research 
population in the United States of opiate abusers and their medical 
treatment (8all and 'Chambers, 1970; Baganz and Ma~dux, 1965; 
O'Oonnell s 1964; Vaillant, 1966, 1968,1973). These studies were 
undermined by two serious drawbac ks: first s the research population 
was composed exclusively of prison-hospital inma.tes and, second, 
readdiction was rigidly defined as any use of illegal drugs following 
release. Thus, these initial follow-up studies concluded that most 
subjects had returned .to drug use and crime soon after release. 
In New York City, an early evaluation of a drug-free program 
for adolescents at Riverside Hospital also concluded that the 
program had 1 ittl e, if any, impact upon patients after their re1 ease 
(Al ksne et al., 1959). This htlS especially damaging due to the wide-
spread belief that younger addicts were more amenable to treatment. 
The poor outcomes .of these early drug-treatment. programs and the 
growing number of drug abusers in the 1960's led Dole and Nyswander 
to reject psychological factors as essential for understanding and 
treating drug addiction. Instead, they concentrated on the "metabol ic 
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deficiencies" which were, they maintained, induced by heroin addiction. 
Methadone maintenance was their suggested remedy. 
Although the metabolic theory remains unsupported in the liter-
ature, treatment programs based on "methadone for life" were, and 
still are, the major form of treatment for opioid dependence. Frances 
Gearing's 1970 and 1974 evaluations of Beth Israel Hospital's 
Methadone Ma intenance Trea 'bnent Program played a significant rol e in 
the growing use of methadone. Gearing maintained--withbut adequate 
controls or breakdowns of patient characteristics--that heroin use 
diminished and became negligible after an initial methadone-maintenance 
period. However, contradictory data ·from other researchers (Jaffee, 
1970; Chambers and Taylor, 1970) showed that heroin use continued 
for many patients. The opposing results might have been due to 
different research variables including patients, treatment programs, 
or research methodology (Lukoff, 1971). 
Gearing a 150 assumed that if the need for heroin a bated, then 
"attendant" crimes would disappear, suggesting .erro.neously that crime 
reduction was dramatic. She made inappropriate comparisons between 
arrest rates of patients who either remained in trea'bnent, were discharged, 
or who withdrew to those who only underwent detoxification. This was 
an error because·the length of treatment was a misleading basis of 
comparison. Obviously, the patient profiles for those who remained 
in treatment may have differed from those who withdrew. 
Indeed, the role crime·has played in an addicts life can 
conceivably lead to different expectations concerning treatment 
outcome. Lu koff (1974) suggested that the type of crime--whether 
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narcotic or nonnarcotic--p1ays an important part in this analysis. 
In a methadone-treatment evaluation study. he sorted criminal charges 
----.---
into three categories: drug-related, assaultive, and property or 
petty crime. Pretreatment drug-related cr'ime, in Lukoff's sample, 
constituted one-third of all crimes. Referring again to Gearing's 
claims about the dramatic reduction in attendant crime after the 
provision of methadone (assuming that methadon'e reduces heroin use), 
then the greatest crime reduction should be in the drug-related 
arrests (Lu koff, 1974). 
However, Lukoff distinguished between the age at onset of regular 
drug use and the age of, first arrest. ,He found that those with arrests 
preceding heroin abuse tended to persist in their criminal behavior. 
In addition, youthful onset of heroin abuse was also linked to higher 
rates of criminal ity compared to those who b,egan drug use later (Lukoff, 
1974 ). 
These findings suggested, according to Lukoff, that the younger 
the age of onset of either dev·iant behavior pattern (drug use or crime), 
the more indicative they were of increased deviance in general. Thus, 
earlier age of drug-abuse onset was associated with higher rates of 
crime, shorter stay in treatment, and poorer prognosis for treatment 
outcome than those who started drug-abuse later in life. Earlier 
drug-abuse onset was also related to the likelihood of less employment, 
lower educat ion, and being unnarried (Lukoff, 1974). Lu koff stated. 
that these findings suppor~ed the thesis that early onset was associated 
with "truncated socialization" in which the important socialiZing 
influences of education, employment, .and personal relationships were 
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incomplete and fragmented. Lukoff concluded that the earlier an 
addict's drug addiction occurred. the more severely inhibited his 
socialization patterns were likely to be. This conclusion may partly 
account for the poorer treatment outcome generally reported for younger 
addicts. 
These foregoing· studies mandate future evaluations which will 
follow up on the work accomplished to date.· For drug treatment 
programs to be fully evaluated. patient profiles must record variations 
in drug use variations,in treatment modalities, and consequent effects 
on patients' psychosocial characteristics. Otherwise, patients cannot 
be matched with the optimum therapies. 
The earlier view of the irreversibility of drug addiction and 
the bel ief that any post-treatment drug abuse, however sl ight, signal ed· 
a return to addiction led to the rigid follow-up criteria of the 
Lex ington, Fort Worth, and Riverside stud ies·. The common assumpt ion 
concerning lifelong addiction was based on these studies and seemed 
reasonable in light of their short-term treatment outcomes. The 
studies' major failing was in focusing on a short-term follow-up of 
a marginal population of· drug abusers, namely, those in the prison 
hospital s and of the adol escent treatment program at Riverside Hospital ~ 
However, a longer follow-up study by Duva.ll et a1. (1963) found 
that by the fifth year after· discharge from the LeXington Hospital 
only 46 percent of the relapsed addicts had become readdicted; Vaillant 
(1966) found a similar relapse rate after twetve years. Winick (1962) 
found a decline in relapse rate between the ages of 35 and 40. and 
speculated that it might have been due to maturation. In a follow-up 
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study of Puerto Rican males who had been treated at Lexington, Ball 
anci Snarr -(1969) concluded that the maturation hypothes-is m-igh-t -ha~e 
-.- -- - -. --been-v a-l-i d-for a pprox ima tel yon e--t h i rd' -of- 'opi'o-id-add-1"ct-s-;-- --Thr-e-e- --------- -
years later Zahn and Ball (1972) found that onset of opioid use among 
Lexington addicts at 16 or 17 years of age could be associated directly 
with a poor prognosis for eventual cure- while onset at 32 years of 
age was most likely to result 1n an ev~ntua1 cure. 
Advances 1n the epidemiological exp10r,ation of what determines 
opioid use have done much to change the heretofore extreme view of the 
opioid user by demonstrating: a) that heroin experimentation did not 
lead necessarily to addict~ve levels of usage for a large segment of 
the sample population; b) that heroin use was not irreversible; and 
c) that controlled use (or occasional use) \filS possible for sane 
individuals. 
In relation to the above, Winick (1962") observed that older 
addicts were underrepresented among known opioid users to such a degree 
that their h,igher morta l1ty rate wa s an inadequate explanation. Winick 
advanced the "maturing-ouf" hypothesis, that is, many heroin addicts 
voluntarily stop heroin use as they grow older. The maturing-out 
hypothesis was reinf:orced in 1967 when Robins and Murphy investigated 
a nontreatment sample of black men in St. Louis. They demonstrated 
that many had used heroin frequently at one time, but then were drug-
free at the time of investigation. These studies were ignored in 
treatment circles until the early 1970's (lukoff, 1976). 
More recently, studies by O'Donnell (1976), Robins (1973) and 
Nurco (1975) have supported the earlier findings of Winick, Robins 
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and Murphy. In 1973 Robins studied heroin use among Vietnam soldiers 
with a one-to-three year follow-up. She found that one-third of those 
detected as users at the time of their discharge from the armed forces 
continued to use opiates after discharge. However, only 7 percent 
were using opiates approximately one year after discharge. These 
findings were relatively stable over the three-year follow-up period .. 
Nurco's Baltimore study was taken from a police register of 
addicts compiled between 1952 and 1971 and were contacted in 1974. 
Among those who were not incarcerated 57 percent were nonusers, 17 
percent were classified as occasional users and only 7 percent were 
regular users. In sum, many previously identified addicts were now 
opiate-free. 
Zinberg (1979) studied a selected group of controlled· users. His 
findings also supported the notion that controlled use without subse-
quent addiction or treatment seems possible for some opioid users. 
If "maturing out" from chronic use·is a viable hypothesis, and 
controlled (or occasional) use is possible, then the success of treat-
ment programs must be evaluated within this context. The above studies 
infer that age at drug-use onset, length of addiction, and age at onset 
of treatment must be considered as covariables; the outcome measure of 
abstinence should be modified to include level and frequency of use. 
These findings are of obvious relevance to the traditional 
assumptions upon which most drug-abuse treatment programs, especially 
methadone-maintenance, are based. For example, the so-called disease, 
or permanent addiction, model is now outmoded. One additional con-
clusion might be that the traditional treatment models' limited success 
is attributable to the patient selection, maturing out, or that the programs 
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merely maintain the addicts until they are ready to· exit the drug scene 
(Lu koff, 1974). 
. ----_.- -------_.- ._-_ .. _. -- .--. _._-
Naltrexone 
The relatively recent advances in understanding the physiologic 
mechanisms of opioids have led to so-called opioid antagonist treat-
ment. The prime ingredient in opioid antagonist treatment is Nal-
trexone, a compound that sel ectively blocks the euphoric and physiologic 
effects of morphinelike drugs, that is, opioids such as heroin and 
methadone. Naltrexone is nonaddicting with no abuse potential, since it 
cannot produce an add 1ct I s "high". 
However, to be effective Naltrexone must be prescribed and ingested 
only after opioid detoxification has occurred. Thus, if a person who is 
no longer physically dependent on opioids takes Naltrex·one, he will be 
protected against readdiction: even if heroin is used, he will experi-
ence no euphoria and will not d~velop opioid dependence (Resnick et al., 
1979). Theoretically, having this protection, the patient could return 
to the community where opioid-free rehabilitation involving behavioral 
and psychosocial therapy can be administered on an outpatient basis 
despite the availabil ity of heroin or other opioids (Wikler in Resnick 
et a 1 ., 1 97 9) • 
The theoretical basis for antagonist treatment for opioid 
dependence was developed by Wikl er (1965, 1973) who suggested that. 
conditioning factors of which n·either the therapist nor the patient are 
aware may be responsible for the relapse to heroin use in detoxified 
addicts. Basing his argument on.principles of operant and Pavlovian 
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conditioning, Wikler proposed a two-factor theory of relapsing behavior, 
suggesting that through the process of operant conditioning the relief· 
from emotional and physical distress provided by an injection of heroin 
constitutes a powerful reinforcement that can establish and maintain 
opioid-using behavior. 
In addition, through repeated pairings between stimuli in the 
addict's environment, withdrawal symptoms and their relief, Pavlovian 
conditioning is triggered. causing a craving for heroin in the 
previously detoxified addict when he comes in contact with these same 
environmental stimuli. This conditioned-abstinence response can cause 
the detoxified addict to reinitiate opioid use and, consequently, result 
in a relapse to heroin addiction. 
Furthermore, according to this model, when heroin-reinforcing 
properties are blocked by the opioid antagonist Naltrexone, drug-seeking 
behavior will cease as a result of the extinction of previously condi-
tioned responses. 
These conditioning factors contribute to the explanation of why 
detoxification treatments not followed by nonopioid pharmacological 
support generally have not been successful (Resnick et a1 ., 1979). 
Essentially an adjunct treatment to cognitive, behavioral, and psycho-
social treatment methods, Na1trexone's reputation rests on its inability 
to produce a noticeable physiological effect. However, it does allow a 
treatment system to develop around the behaVioral, psychosocial, and 
physiological explanations of drug-using behavior--as opposed to the 
limited biological notions methadone-maintenance programs have labored 
under for so long. 
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Martin (1966), an early pioneer in using opioid-antagonist treat-
ment, stated three objectives for the opioid antagonist in its rol e as 
opioids; b) to extinguish the conditioned-abstin·ence response; and c) 
to facil itate an outpatient abstinence period. Commenting on this last 
objective, Wikler (1980) stated: 
Such a period of outpatient status would have advantages over 
detoxification followed by forced abstention from opioids (by 
prison sentences, probation, hospitalization,·etc.) in that 
it would permit the patient to expose himself to the. conditioned 
environmental stimuli which evoke craving without the danger of 
their reinforcement by the pharmacological actions of opioid 
drugs. 
Thus, psychosocial and behavioral treatment techniques can be stressed 
in a low-risk outpatient treatment period which, in the opinion of the pre-
sent author is a requirement for successful treatment. 
Li ke other treatment moda l1ties Nal trexone, coupl ed with psychosoc ial 
treatment, may be useful for only a select group of patients such as those 
motivated to curtail use but unable to remain drug-free during the initial, 
critical period of resocialization. As stated previously, it is impera-
tive, therefore, to identify patient characteristics that would seem to 
indicate a successful treatment outcome. 
Although, in. theory, the opioid antagonist as an adjunct ·treatment 
has great potential, earl y ind ications seem to suggest that Na ltrexone 
has been used to date only in isolated cases. An essential at this 
early stage in its evolution as an opioid antagonist should be to 
standardize prognostic and evaluative data-collection instruments. 
The goal, of course. should be clear-cut identification of the ideal 
conditions and population for use of this treatment technique. 
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Currently, as in the norm with experimental drugs, the use of 
Na1 trexone as an opioid antagonist ha s drawn mbed rev iews. For examp1 e, 
reports of Na1trexone ' s clinical efficacy have indicated high preinduc-
tion dropout rates and poor retention of those patients who began 
treatment with Na1 trexone (Bradford, 1976). In re.sponse one researcher 
has concluded that Na1trexone may be useful only for a select group of 
highly motivated addicts (Hollister, 1976, 1978). Another approach to 
developing a Na1trexone strategy.was to assume that treatment problems 
were a function not only of unmotivated patients, but also of the 
manner in which Na1trexone has been used (Rawson, 1979). The overriding 
importance of effective counseling and psychotherapy as treatment tools 
in conjunction with Na1trexone has been stressed by Wikler (1976), 
Resnick et a1. 1976, and Resnick and Washton (1978). 
Too, Rawson (1979) and Callahan et a1. (1976) evaluated the 
benefits of Naltrexone combined with behaviorally structured therapeutic 
support and concluded that Naltrexone plus behavioral therapy was marked-
ly superior to Na1trexone alone. Superiority in their studies was 
defined as retention in treatment; in other words, those who took 
Na 1 trexone tended to rema in in treatment longer. Treatment dura tion 
as a measure of·superiority is also supported in the literature by 
Resnick and Washton (1978) who reported follow-up data for 267 N~ltrexone 
patients over varying periods before voluntary termination. Among· this 
study population the opiate-free patients had taken Naltrexone for a 
significantly longer period than those who became readdicted. Greenstein 
et ale (1976), Lewis et a1. (1976), and Callahan et a1. (1979) also 
.. 
found that longer Naltrexone maintenance contributed favorably to treatment 
outcome. 
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The problem here is that retention in treatment may be caused by 
other factors besides the type of pr,ogram offered. Specifically the 
'------'--'-patient type may be the determ'i-nfng-facto,,"that'contributes 'to longer 
retent ion in treatment. This study's research design precl ud,es 
answering the question as to what causes a patient to stay in treatment 
longer. In the present study patient type is' equally 1 ikely to facil i-
tate retention in treatment as is program type. 
In another recent study Rawson, Resnick and Washton (1979) com-
pared low and high intervention groups--10w meant no psychotherapeutic 
involvement while high meant r~gu1ar weekly psychotherapeutic involve-
ment--finding that the high intervention group had a si,gnificant1y 
longer stay in treatment. 
Other factors which appeared to influence Nal trexone I s success as 
an opioid an~agonist were the type of opiate addiction, tha~ is, heroin 
or methadone, and the use 1 eve1 immediately prior to detox ification and 
beginning Na1trexone. The available findi,ngs indicated that methadone 
maintenance subjects had a higher induction rate onto Na1trexone than 
did heroin addicts. The data also suggested that the lower the level 
of opioid dependence, the more likely the success of the subsequent 
Na1trexone treatment (Rawson et a1., unpublished manuscript, 1979). 
Resnick et a1. (1970) developed a typological classification in 
an attempt to identify those drug abusers most likely to ,benefit from 
opioid-antagonist treatment. Two major groups of drug abusers were 
found to have different treatment outcOO1es: a) se1f-med icators, that is, 
those who, when drug-free. reported having impaired capacity to function 
and who appeared to use opioids to rel ieve s.Yl1lptoms of chronic emotional 
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problems and/or stress; b) envfromental users, or those who did. not 
have overt emotional probl ems and who. when d.rug-free, did not report 
an impaired capacity to function. The former group discontinued treat-
ment prematurely whil e members of the 1 atter group, on the average, 
stayed in treatment longer. 
In relation to the above groups Haertzen (1966) developed the MBG 
Scale (Morphine-Benzedrine Group Scale),·callfng it a useful measure of 
the euphorigenic actions of drugs. This scale measures feeli:ngs of 
well-being, popularity, and efficiency, the opposites of hypophoric 
states. 
Martin et al. (1971)and Jasinski et ale (1971) contrasted 
euphoria and hypophoria, using the MBG Scale together with doses of 
morphine, amphetamines, and pentobarbital. They found dose-related 
elevations of MBG Scale scores, indicating that these drugs might have 
been u sed by patients as an antidote to their hypophoric feelings as 
well as to produce feelings of well-being (Martin, 1980). 
Later analyses by Rawson et al. (1979) and Resnick et al. (1978) 
found dose-rel ated treatment outcomes where "higher 1 evel s of opioids 
at intake were inversely related to success rates in treatment". 
McLellan et ale (1980) studied the relationship between severity 
of chemical abuse and the status of other problems on the Addiction 
Severity Index (AS!). They found "moderate general" relationships in 
both improvement scores and in outcome status measures between the 
psychological index and reduction of drug use. They went on to say 
that "it has long been specul ated that ••• psychological probl ems are 
the basis for many forms of addiction. and that chemical abuse may 
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serve as medication for these underlying problems" (Khantzian. 1974; 
Wurmser. 1979; Woody and Blaine~ 197~). 
--- ------ ------Th-e-d-ose-rel atedhj"pophor-ia- resu-1Tsof. Martin (l980)-:--plus - ------.---- ----
Resnick et al. (1978) and Rawson'.s et al. '(1979) findings of more 
positive treatment outcomes for lower levels of addiction and 
McLellan's et al. (1980) ASI findings are important when consid.ering 
outcome and need for s.YRIptom red·uction. 
Presently, determining Naltrexone treatment efficacy bas been 
1 imited by program evalu ations which have inadequately accounted for 
variations in program-acceptance criteria '. geographical location, 
and the consequent variation in patient parameters. The significance, 
for exampl e, of geographical location is that the cul tural mil ieu may 
quite possibly differ for Chicanos in los Angeles and blacks in 
New York. As in the earl ier methadone evaluations, acceptance 
criteria alone coul d accoont for the varying success ratios claimed. 
by the different drug-treatment programs. 
Psychosocial and drug-history variables that are more common to 
successful patients (success being defined as abstinence or a longer 
time in treatmen't) include the foll owing: a) evidence of an ongoing 
personal relationship with a nonaddict mate; b) maturing out after a 
long history of addiction; c) regular employment; and d) previous 
psycho-therapy. When these v ariab1 es are adopted as acceptance 
criteria by drug-treatment progr.ams. they resul t in the acceptance 
of generally older addi cts. Thus. such a program might be expected 
to record a higher success ratio than a program which admitted 
younger as well as older patients. 
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Call ahan et al. (1976), us1.ng random1zed clinical tri al 
methodology, based their acceptance of a patient into a Naltrexone 
treatment program on the patient's willingness to sign a contract 
agreeing to comply w1th program rul es and regul ations. This method 
eliminated the step of specifyi.ng soc1allyacceptable behavi.or, 
rep1 aci ng it instead with psychol.og1ca1 cr1teria encompassi.ng 
commitment and motivation. 
Psychotropic Drugs 
The literature on the efficacy of psychotropic drugs in 
the treatment of drug-aw$e is nonexistent. The pr1mary reason, 
of course, is the general prohi b1tion within ttie treatment 
community of pres~r1bing drugs to drug addicts except in the case 
of methadone, which has only 1 imited acceptance. 
Conc1u si on 
~lhi1 e the criteria discussed above may serve a 1 egitimate 
treatment function, they are no substitutes for a thoroughgoing 
exploration of patient histories and. the develor:xnent of outcome 
criteria which adequately measure a drug-treatment program's 
psychOSOCial effects on different patients. Until these concerns 
have been addressed, it will remain impossible to be certain of 




As a national problem drug addiction is widespread in the 
urban centers of this country. The" most obvious victims of illegal 
drugs are the habitual consumers, that is, drug addicts. As seen in 
the preceding chapters of this study, the bureaucratic change within 
the drug treatment response has been in response to emerginQ 
social problems. When drug addiction swept into the American 
middle class during the 1960's and 1970's. new solutions for the 
probl em were denanded. 
In choosing which of the many drug abuse treatment programs to 
evaluate in the New York City metropolitan a~ea, a number of constraints 
were deemed important: first, a program which had not been the subject 
of previous study; second, a patient population which had not been 
studied before; and t~ird, free and open access to the treatment 
program, the patients enrolled in it, and the physicians and other 
staff members responsible for the program's operation. 
Although a number of candidate programs meeting the above 
criteria were located within metropolitan New York City. the drug-abuse 
treatment program at this hospital was selected as the most prani.sing 
for the purposes of this study. The treatment program was stable, 
if relatively new. having been in place for approximately three 
years. In addition, its patient population--the"majority of whom were 
young, white, affluent males--presented a rare opportunity for scrutiny 
of a sector of the drug abusing population which had been 
v irtuall y ignored. In this case, the hospital, as a private" 
institution, was not in need of government funding. Thus, 
lack of funding resulted in a lack of motivation by outsiders 
to conduct research there. 
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In discussing this study, one must be careful to emphasize the 
patience and understanding required of the researcher during the period 
of preliminary negotiations with the host program. No matter how well-
recommended the researcher might be, or how closely the research goals 
and proposal s are set forth, one should be prepared to wa it a consider-
able period prior to acceptance, appreciating the dilemma confronting 
the programls administrators. namely, that an outsider often is viewed 
as a potential threat by staff members because a program evaluation 
might lead to adverse publicity and, consequently, a loss of patients. 
One should also remember that time is required to fit a new researcher 
into the flow of an on-going treatment program. Too, one might be 
well-advised to answer even the most routine questions in a cooperative 
spirit no matter how often a question is repeated. 
Once a research proposal has been accepted, then the real work 
begins. New patients were accepted into the program throughout 
the year, the average number during the el even-month research 
period being apprOXimately two hundred. By the time agreed upon for 
research to commence, the researcher was generally familiar with 
the format of the hospi tall s drug abu se treatment program becau se 
he had made site visits to the hospital a number" of times to discuss 
his proposed research and, in turn, had been briefed by staff members. 
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In general, the plan was to follow ~ grou.p of _101_.consecutive 
patient admissions to the dr.ug abuse treatment program tbrough 
... --- -------------- --------
--- --- - - .. - --- - ----:----:-
each stage in the p~ogrilll ·includi.ng their participation in the 
hospita l'.s outpatient therapy. A three-part study design, entitl ed 
Pre- and Post-nonexperimental De~ign. was envisioned: 
First, the praneasuranent consisti.ng of a patient interv iew 
anploying the full Addiction Severity Index (ASI) plus a natural 
support system matrix and drug history variabl es. 
Second, treatment process data, medication used, and patient 
status at discharge. 
Third, a postmeasurement consisting of a telephone follow-up 
interview approximately three and a half months after discha.rge 
enploying the composite AS! plus a natural support system matrix. 
The Addiction Severity Index (ASI) is a diagnostic and 
eva luative ·instrument. The AS! produces a ten-point probl em 
severity profile of each patient through an analysis of six general 
areas that commonly pose treatment problems. The areas are: 
1) chemical abuse, 2) medical, 3) psychological, 4) legal, 5} family/ 
social and 6} employment/support. 
1 In add ition to the two interv iews and the ASI, the research 
'f::J.t..e.t --f·.c 
data base wa~ composed of patient f;1 es and pharmacy records, the 
Brief Psychiatric Inventory, and the Beck Depression Scale. 
(Overall et al: 1962; Beck et al. 1961) 
New admissions to the dr~g-~buse treatment program were 
..... 
isolated in the hospital's intake unit for a period usually not 
exceeding seven days. In effect, this was the d·etoxification 
unit for the program. Prior to being admitted for inpatient 
treatment, each patient was interviewed by a staff member and 
required to sign a contract stipulating, among other things, that 
the patient would abide by the program's rules and would not leave 
the program without giv ing at 1 east seventy-two .hours notice. The 
goal here was to make each patient responsible for his own actions 
and to confront the patient with the responsibfl1'ty for completing 
the program. 
The drug abuse treatment program was well suited to research 
purposes because of its stability and the incorporation of 
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mu lti pl e treatment modal ities su.pported by a comprehensive treat-
ment team including, as stated previously in Chapter I, social 
workers. psychologists. psychiatrists, ex-addict counselors, 
psychiatric nurses, medical internists, and recreational therapists. 
The psychosocial treatment modalities focused on·individual psycho-
therapy and drug counseling as well as group psychotherapy, drug 
group meetings, family therapy, multiple family groups, and 
physical exercise. 
Interfaced with the strong psychosocial treatment model was 
biochemical support in the form of clonidine hydrocloride for 
opioid detoxification and psychotropic medication used when severe 
psychiatric symptoms were apparent. 
With these facts in mind it is important to note that this 
study was not intended to tease out the impact of all of these 
services. However, the treatment infonmation concerning patient 
attributes and length of stay in various treatment modalities is 
-- ------- -:----
empbasized as are the direct effects of the biochemical treatments 
offered . 
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The specific psychosocial t_reatment modalities included a 
modified treatment community approach in which the inpatient 
emphasis was on psychosocial support (for detoxifyi_ng) that came 
from the staff, other patients, and family members. Da i1y drug 
groups and psychotherapy groups met three times a week and were 
designed to deal with the many feel~ngs the patient experienced 
daily whil e undergoi,ng detoxification. These groups stressed 
appropriate social behavior that was acceptable in primary-group 
living arrangements. 
Family supportive involvement was emphasized on entry to tbe 
facility, during detoxification, and was heavily stressed during 
the outpatient phases of treatment. The fami'ly emphasi s was 
intended to encourage a noninstitutional type of support for the 
detoxified addict by the family and/or conjugal unit, who would 
be in daily contact with the patient. Support for this line of 
thinking came from the perceived increase in post-hospitalization 
treatment protocol compliance by patients whose families were 
actively involved in the treatment process. 
A primary goal in treatment was, of course, to mobilize a 
combination of professional treatment and primary group support 
in order to realize the ultimate benefit for the patient. 
Litwak (1978) stated that it is often necessary to have both 
types of tasks perfonmed by both groups, professional and primary, 
if the overall objectives of a given endeavor are to be accompli shed • 
Both groups have their own tasks that they are most suited to deal 
. with. For example, major problems in mental and physical bealth 
care requ ire large-scal e institutions and/or professional hel. p. 
Professional experts are necessary for handl i.ng uniform tasks 
such as detoxifying addicts. The deve.lopnent of physical 
S)11IptomS (common in detoxification) which: impede everyday living 
often makes it difficult for anyone to live with the patient. 
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When the detoxification phase of treatment is successfully completed, 
one must recognize there are everyday forms of temporary mental 
stress that require nonuniform tasks which experts are unavailable 
to handle. 
Litwak (1978) suggested that optimum mental health care is 
produced where individuals have nonexperts they can rely on to 
handle the daily fleeting sou'rces of anxiety while al so having 
professional experts and institutions to handle the more enduring 
forms of anxiety. 
Some studies have suggested that psychiatric patients 
returning from instit~tionalization must have primary group support 
if they are to succeed (Litwak 1978). The natural support system 
consists of families, friends, neighbors and kin. Following 
Litwak, the primary group is defined as small, face-to-face, 
noninstrumental, having diffused goals as well as being affective 
and having long-term commitments. 
The drug treatment unit utilized inpatient professional 
treatment and inpatient self-help groups that resembled family 
relations. Inpatient status required the addicts to live together 
----- ----- --.----
on a twenty-four hour basis in a family-like tie-. Addition.ally, 
there was gr.eat emphasis on the mobilization of primary-'group 
._-- . ----.-.-----
--su'p'por-t-n-et-warks in order to facilitate the patients reentry into 
the community and encourage compliance with the ~utpatient phase 
of the treatment protocol. 
During the detoxification period t. medical evaluation and 
stabilization of the patient took two forms--walk rounds and 
patient rounds. Walk rounds occurred on Tuesday and Thursd·ay. 
Here, a multidisciplinary team of, say, three people visited each 
patient for a few minutes. 
Pat ient rounds were more elaborate and_ occurred on Monday. 
Wednesday, and Friday. The patients met i_ndividually, and 
privately, with an assanbled multidisciplinary team for ten to 
fifteen minutes. Each patient was summoned to' the meeting room 
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by an attendant. The team was' able to interview ten to fifteen 
patients in a two-and-a-half-hour-to-three-hour span. Thus, each 
patient attended patient rounds three times a week. Patient rounds 
reinforced the patient.contract in that the meetings involved direct 
~estio~ing of the patient by staff members about his condition 
including prior confl icting statements made by t.he patient. 
The patients al so received the usual nursing (iare routines 
provided in a hospital environment. The goal of detoxification 
was to promote each patient into the second treatment stage--the 
drug-free unit--as quickly as possible. At the hospital the team 
concept was an integral part of the hospital's strong treatment 
model. Specifically, each staff member involved in medical 
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treatment and/or patient rehabilitation was considered an essential 
part of the treatment proceSs. Staff meetings to discuss patient 
care were held three times a week,prior to patient rounds. During 
these meetings the files of patients undergoi.ng detoxification 
were reviewed. It is important to emphasize here that the researcher 
was welcomed to all staff meetings, accompanied the staff during. 
rou nds, and, for practical purposes, was considered a research and 
partic ipant observer member of the team. 
The Detoxification Stage 
During the period of this study, February 1982 to 'December 
1982, a typical day in the detoxification unit included a patient 
population of ten to fifteen. During one week an average of four 
patients were admitted to the unit. New admissions were by appoint-
ment, that is, the pat ients arrived at a prearranged time which 
coincided with the availability of beds. Normally, patients were 
housed two to a room--semi-private accommodations. The occasional 
cel ebrity patient or. other patient desiring soHtude arranged, at 
a commensurate rate, for a private room. 
Breakfast was followed by either walk rounds or patient rounds. 
Since the researcher was accepted by the patients as part of the 
staff (he attended rounds). patients in the detoxification unit were 
not alarmed by the appearance of the researcher, who then requested 
an interview from them. A research goal was to conduct the initial 
interview within, at most, the first week of admittance to the 
d etox ification unit. 
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Duri.ng the five-month period February 1982 thr~ugh June 1982, 
101 patients were interviewed in the detoxification unit. If the 
.... _pat.tent. ·wa-s unava n abl e--for ani'nterv ifirf61Towfng--morn-ing rourids,--
. . 
then the researcher returned in the afternoon. The interview 
instrument, the ASI, was a multica~egory format of primarily 
forced-choice questions. Typically, an interview was conducted 
in one session and 1 asted forty-five minutes to an hour. 
To describe the patients' demeanor as serious at this s~age 
would be, in most cases, an understatement. Typically, patients 
enrolled in the dr.ug abuse treatment p~ogram becau·se·dr.ug use had 
become their overriding concern and they no longer were in control 
of their own actions. In fact, they were desperate. 
In the afternoon the prescriptions of the morni.ng were carried 
out including individualized treatment in the fonn of social work 
group cou.nsel i.ng and/or one-on-one sessions with an ex-addict drug 
counselor. The detoxification protocol included the prescription of 
Clonidine to co~nter the patients' abrupt cessation of opioid drug 
use. The starting dose of Clonidine was 1.7 micrograms per millegram 
which was then varied as needed based on a close perusal of each 
patient's vital signs and verbal reports of discomfort. The starting 
dose usually was given on the first day of detoxification. 
At the hospital the more quickly each patient responded to treat-
ment, the more involved the patient became in his own rehabilitation,. 
for the highl y structured treatment model focused on reactivati ng a 
patient as quickly as possible. The treatment philosophy was supported 
by an array of counsel i.ng and therapeutic tool s at both the detoxifica-
tion and drug-free 1 evel s. In effect, staff members had a considerabl e . 
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variety of treatment modaHties to offer the patiel')t. However, d.ue 
to the programmatic format, most patients participated 1n all 
planned activHies. 
Following the researcher's first week at the hospital ~ he began 
to monitor the progress of those patie.nts who were promoted to the 
drug-free unit. As stated previously, page 34, this was done not for 
data-collection purposes. but rather to further observe hospital 
routine and obtain patient a~ceptance. Thus. the plan of observation 
widened as part of each day was spent in the detOXification unH and 
part in the drug-free unit. After an initial period of eight weeks, 
research was again broadened to include the monitoring of patients 
who had reached the outpatient stage of tbe program. Here, business-
office records were consulted to confirm discha.rge status. In mid-June 
interviews in the detoxification unit were completed and in mid-July 
follow-up interviews .convnenced--approximatelY three and a half months 
after the first interviewees were released from the hospital. 
At this point it is appropriate to state that the researcher spent 
four days a week. Monday through Thursday, at tbe hospital during the 
research period; the balance of time was used in coding data for com-
puterization. The research file on each member of the study population 
contained approximately 175 pieces of information. The researcher kept 
his files at· home. taking them back and forth to the hospital each day, 
where he was assigned a desk and chair in a SOCial work staff office. 
The Drug-Free Unit 
As in the detoxification unit. life for patients in the hospital's 
drug-free unit was highly structured. Patients received individual and· 
group counsel ing and partfcipated in a host ot: group treatment ~nd. 
recreational activities aimed at equi.ppi.ng them to cope with 1 ife., 
--. --------- ---- -----wit·holft-n-l egin drugs, after -completfng--ffle-eight-week -inpa~ ient 
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program. The medical staff also.engaged in daily treatment planning 
meeti.ngs; and patients participated. in d.a1.ly group therapy sessions. 
Ind iv idual and group therapy in the drug-free. unit continued 
the modalities introduced in the detoxification un1t. Drug-group 
sessions were held five times a week and multifamily support groups led by 
a soc ia 1 \\Orker, ex-add ict drug counselor, and psychiatr ic nurse, 
met one time a week. Individu.al therapy was based on thrice-weekly 
sessions with a psychiatrist or psychologist. Counsel i."g for sexu.al 
dysfunction was schedul ed as requ ired. 
Medically, as detailed in Chapter· IV, patients were prescribed 
psychotropic drugs as part of their rehabilitation when severe 
psych.i.atric s~ptoms were apparent. As in detoxification recreational 
therapy in the g~nasium was prescribed on a daily basis for all 
patients. Within the context of the drug-free unit the researcher's 
role was to attend treatment planning meetings, monitor the progress 
of the original interviewees from the detoxification unit, and chart 
the admini·stra-t-ion of detox ification and psychotropic drugs to tfle 
study population. 
Outpatient Therapy 
After completion of inpatient treatment patients were expected to 
partiCipate in the outpatient stage of the program. However 
this cormnitment was not always adhered to, and thus the ou.tpatient 
treatment was administered to only part of the patient population. 
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Basically, patients were expected to attent five-time-a-week group-
therapy sessions, and could attend one to three times per week as 
they resumed outside activities. 
Some patients fulfilled their obUgation and attended faithfully 
wbil e otbers--particularly those who became readd icted--qu ic kly d.ropped 
out or attended sporadically. From the researcher's viewpoint, the 
advantage of the outpatient p~ogram was that the results or lack of 
results from the researcher's follow-up interview could be compared 
with the resul ts noted by the outpatient pr.ogram staff. 
As stated previou.sly, the follow-up tnterviews were conducted by 
tbe researcher apprOXimately three and a half months after release 
from the inpatient pr.ogram. Based on th.e t01 initial interviews 
in the detoxification unit. 97 follow-up attempts were completed. Of 
these 97 follow-up attempts~ 64 full follolr4lp ASI interviews were con-
ducted successfully, that is, the ex-patient was contacted and responded 
to the interview questions until completion. 
As stated previously, these were telephone interviews; a multiple 
callback procedure was followed. In some cases, the researcher 
attempted unsuccessfully to contact interview subjects on as many 
as fifteen separate occasions. 
In some unsuccessful cases contact was made, then broken off by 
the patient; specifically, the ex-patient declined to be interviewed. 
A typical response was that the_drug addiction and subsequent treat-
ment had been a pa infU 1 chapter in the su bject' slife and that he had 
no deSire to reawaken unhappy memories. In other cases, the su bjects 
refused to come to the telephone or were otherwise unlocatable, a 
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second party sayi.ng that the subject was not there or had moved away 
without leavi.ng a forward.i.ng address or·telephone number. 
_._-------- ------
Conclusion 
The "hospital's drug-abu se treatment pr.ogram offered a study 
population which had. rece'ivecf.'scant·attention from psychosocial 
research.ers. The program was staff-intensive. allowing for 




Sampl e. The sampl e cl early does not represent the total 
fabric of the addicted population that enters treatment. Therefore 
generalizablllty of results is limited, to only the treatment 
population studied. 
Design. One-group dependent measures designs suffer from the 
inability to truly attribute (pre-post) change to the treatment 
intervention itself. 
Change may be due, in part, to the pre-measurement "sensitizing" 
of the individual to factors that occur between the measures, thereby 
confounding memory and self-report, especially if one is measuring" 
variables that are highly reactive (Campbell 1966). 
Two other important sources of extraneous variance are history 
and maturation. Kerlinger (1973) points out"that the longer the 
period of time between measures, the greater chance of these variables 
affecting the reported outcome. Regression effects also must be 
considered as inherent with this type of design. 
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CHAPTER 4 - -----
THE RESEARCH DATA 
-- ------ ------ --- -------
Of the 101 patients in the hospital"s drug abuse treatment 
program who wer.e interviewed at the Intake stage, and thus 
composed the research population, 74 completed the inpatient program, 
25 1 eft the hospital prior to compl etion, and 1 died whil e in the 
hospital and 1 ~s the result of a drug overdose after release from 
treatment. During the postmeasurement period, camnencing approximate-
ly three and a half months after discharge from the in-patient program, 
followup data was completed on gJ of the 100 patients released from 
the hospita 1 . 
Sixty-four. of these 97 patients participated in followup inter-
views while the :remaining 33 patients, as stated previously (page 
39), were gener.ally unreachable or uncooperative, volunteering little, 
if any, information and often decl ining even to speak to the investiga-
tor. Thus, information on this latter patient group was necessarily 
obtained from secondary sources such as friends, family members, 
and drug counselors in the outpatient program. 
As both the pre- and post-measurement interviews were self-reports, 
it is important Ito note that McLellan (1983) found less than a 5 per-
cent inconsistency when he performed spot checks of his research 
population, asse,ssing the ASI data in the light of urinalyses, 
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pharmacy records and law-enforcement fil es. Similar find i.ngs have 
been reported by other investigators includi.ng Sobell et al. (1975), 
Bale et ale (1977), and LaPorte et ~l. ·(1980. 
In add it ion to the above data. it is appropriate to note 
here that 51 patients were readdicted at followup, ·46 were dru.g-free 
and 4 were unclassifiabl e as to dru 9 stat",s. Al so. ·20 readdicted 
patients reentered treatment for drug abuse prior to followup. A 
1 ist of d.rugs as d.efined in the present study can be seen in Appendix 
B. 
Table 1 ·breaks d.own the patient demographics of drug addiction 
at time of entry to the hospital as we·ll as the race and rel igion of 
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Comparison of·Demographic Characteristics 
A comparison of demographic characteristics among different 
treatment populations is often difficult beCause of wide variations 
in coll ection and reporting techniques. In the case of the 
present stud·y, the drug abuse treatment program was unusual in 
that it was an inpatient facility and, as stated previously, cost 
approximately $6,000 per week for a dOUble-occupancy room. These 
conditions influenced the composition of the patient population in 
at least two distinct ways: first, the patients were generally 
more psychiatrically dysfunctional than patients in many 
outpatient programs for d.rug abuse (ou.tpatient programs 
pred.ominant in treatment of drug-abusing populations). And 
second, the family of the patient was wealthy. the patient was 
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well-to-do in his own right, or the patient had excellent insurance, 
a characteristic of wealth, large companies and union jobs. In fact, 
employee-assistance p~ograms accounted for 18 percent of the research 
population. 
Among the parents of patients in the research population, 
parents of 66 patients were reported to have an income averaging 
$102,000 a year with a range of $10,000 to $1,500,000. Parents of 
35 patients were reported as having no income or as retired. 
Eighty-one patients reported incomes, ranging from $12,000 to 
$1,000,000 with an average income of $44,732. Some of the 20 patients 
who claimed no income were the beneficiaries of trusts which 
might have put them among the wealthiest of the patients. These 
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figures contrasted sharply with those of most urban drug addicts 
undergoing treatment; their reported incomes ranged from $4,000 to 
-- ----------$g-;OOO--(for c-Oiitparisons of Income se:e -Ta-ble-~}~- ------ .-- - - --"---
Seventy-five percent of the research population reported a 
profession, trade or skill wh"ile 25 percent reported no job training. 
Sixty-e1ght percent said-they worked full-t1me, 27 percent part-time 
or were students, while only 5 percent said they were presently 
unemployed. In comparison to other studies, the present research 
population had a m1nute fraction unemployed. McLellan et ale (1982) 
reported 62 percent with a profess10n, trade or sk1ll; Resnic k et al. 
(1978) reported 54 percent employed; Tennant and Rawson (1981) 
reported 55 percent employed while Sell s (1979) reported only 33 
percent employed. The average educational level of the research 
population was 13.5 years. This average was high compared with 
other studies. McLellan (ibid. 1982) reported 11.7 years, Resnick 
(1978) reported 11.3 years, and Tennant (1981) reported 11.5 years. 
Clearly, the present research population was unusual in regard to 
income, education and employment. 
As can be seen ;n Tabl e 3, the rac;a 1 compos ;tion of the. 
research popul at ion was 78 pe.rcent white, 18 percent Black 
and 4 perc ent Hi span ic . 
In contrast, McLellan (1982) reported 47 percent wh1te and 52 
percent non-white, Hunt (1977) reporte~ 26 percent white and 73 per-
cent non-white, and Sells (1977) reported 52 percent white and 48 
percent non-white. The range from this sample of treatment 
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Author N Age % White Whfte 
Resnick 81 27 
Wa shton 
McLellan 272 30.5 37 63 
Ockert 101 28.59 83 18 
TABLE J..-CONTINUED 
DEMOGRAPHIC COMPARISONS 
% % Years of 
Male Female Educatfon 
11.3 
100 0 12 
78 22 13.5 
Average 
Number of 
Years of Treatment Area 
Addictfon Episodes Year 
7.5 New York City 1979 
Average Age of Onset 19.5 
53% Employed 
37.5% Married 
8.5 3.5 Philadelphfa 1982 
7 3.3 New Jersey 1983 
Average Age of Ffrst Arrest 19 
Average Age of Onset 18.53 
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racial composition was another distinguish.ing feature of th.e present 
research population. 
The percentage of men to women in the research population was 
78 percent to 22 percent--within the range of other studies surveyed 
in Table 3 with one exception: McLellan studi.ed the population 
of a Veterans' Administration hospital. 
In regard to age, the· research popul.ation's average age at entry 
was reported as 28.5 years old and ranging from 18 years old to 48 
years old. The o·ther studies used in this comparison ranged from an 
average age of 22 years old to 31 years old at entry to treatment. 
Other demographic indicators are presented in Tables 3 and 4. 
These indicators relating to drug and legal history are noteworthy 
even though comparison data are rather sparse. For example, the 
average age of first arrest in the research population was 19 years 
old while the average age of addiction to the primary drug of choice 
was 18.53 years with an average of 7 years of addiction at entry 
to the hospHal. 1m comparison, Tennant (1981) reported an average 
of 10.7 years of addiction, Resnick (1978) reported an average of 
7.5 years and McLellan (1982) reported an average of 6 years of 
addiction for patients at entry to treatment .. Sells (1975) reported 
an average age at first arrest of 17.9 years with age of onset of 
addiction to primary drug of choice as 16.6 years. Age of onset of 
drug addiction reported by Resnick (1978) was 19.5 years. 
The average number of previous treatment episodes that patients 
had had upon entry to the tnspital was 3.3; McLellan (1981) reported 
an average of 5 treatment episodes, Tennant (1981) reported 
Age of First Drug Use 
Age of Onset of Regular Use 
of Major Drug Abuse 
Money Spent on Drugs and 
Alcohol Monthl y 
Number of Treatment Episodes 
~einduction Druqs of Abuse--
Genera 1 brea kdown 
Referral Source Origin 
Controlled Environment-prior 
to Treatment Entry 
Years Add icted 
I = mean. 
TABLE 4 
DRUG HISTORY VARIABLES 
x = 13.85 years 
X = 18.53 years 
~7gS X = I, $ 
Alcohol 
1" = 49 $ 
X = 3.3 
87%- opioids 
38% sel f 
82% No 
x = 7 years 
Range = 6 to 23 year~ 
Range = 12 to 46 year:s 
Range = 0 to 9,000 $ : 
Range = 0 to 600 $ 
Range = 1 to 20 Episodes 
13% Cocaine 
I 
I 18% Employee Assistan~e 
Programs I, 
41% Other Treatment Sources 
18% Yes \ 
I 
I 




an average of 3.2 episodes and Mclellan, in a later study (1982). 
reported an average of 3.5 episodes. 
In summarizing the significance of the statistics 
presented above. one might conclude- that, in contrast to the 
reports presented in the comparison studies, the present 
research population was composed primarily of middle-class 
and upper-middle-class male. white, drug abusers in their 
late twenties. At the same time it is important to emphasize 
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that, with rare exceptions, the available literature focuses on those 
subjects who had arrest records and/or received treatment for drug 
abuse from federally supported drug-arose treatment programs. 
As pointed out previously in Chapter 3, the -hospital was 
privately owned and supported, receiving no direct government 
subsidies. Thus. while research populations comparable to this 
hospital's may in fact exist, the literature does not discuss them. 
Antecedents That Predict Outcome 
Variation in operationalization of outcome variables. The two 
major outcome variables used in the data analysis were, first, a post-
treatment drug-use severity rating which was a ten-point problem 
rating on the Addiction Severity Index (ASI). This drug severity 
index specifies, among other things, the amount and kind of drugs 
used at followup, the frequency of use, the amount of money spent on 
drugs, the pat ients' subjective judgment of their need to enter treat-
ment again, and how the patient rates the extent of his-drug problem 
(See Appendix C-3). The post-treatment drug-use severity index was 
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used in most correlation and regression analyses in this study. The 
- second major outcome variable was drug-use outcane at follo\\llp a 
_______ d_ic.ho-tomous variable--th-is was essent-ially-a-juCigm-entmade -by th-e-- ----
researcher as to whether the patient was readdicted at followup. 
The key indicator was whether the patient was currently using 
drugs regularly at addictive levels. For example. if a patient 
was reported to have used drugs only once within the average 
three-and-a-half-month period between release fran the inpatient 
program and followup contact, he was judged to be not involved in 
drug-us ing. 
The dichotomous drug-using outcome variable was assigned in 
97 cases (Drug use outcome group). This included the patients in 
the 64 patient-to-researcher followup interviews (Drug use severity 
group) and the aforementioned secondary sources in the other 33 
cases including outpatient staff msnbers, family members and 
friends, and employee-assistance counselors at the patients' place 
of employment. 
As in any study, variables are subject to underlying restric-
tions. Here, the post-treatment drug-use severity rating was 
dependent on tal king directly with a patient and, as pointed out 
previously on page 39, 64 patients among the research population 
sutxnitted to the fol1o\\tlp interview. Therefore the post-treatment 
drug use severity group is a selective population because only 64 
patients were contacted and submitted to the followup interview. 
.----- --
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One might appropriately note here that fo110wup interviews 
or contacts have long been considered among the more challenging 
research problems. Indeed, a common assumption has been that a 
readdicted patient will be more difficult, or even impossible, to 
reach at the follo\\Up stage because of a less stable living environ-
ment. 
Ta b1 e 5 below cross-ta bu1ates foll owup interv iews with drug 
use at followup. 
Using Drugs 




















As one can see above, 64 su bjects in the research po.plJ 1 at i.on 
had com p 1 eted AS I f 0 11 0\\\1 ps and 33 did not, a 1 thoug h knowl edge 
. --- - ------------
-------- ----c-f d'rug use was known. As discussed, those with completed 
fo11owups were significantly more likely to be d'rug-free at 
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-- - - - - --- - - --
follo\tA.Ip than those who were not contacted personally for a followup 
interview. These results should be kept in mind because of their 
effect on the following analyses. 
When examining factors antecedent to treatment that predict 
outcome on fol1o\\\lP. it is important to d-etermine what factors, 
taken alone. have an effect on outcome. Then it is important 
to look at additional variables that may add to the under-
standing of the variance explained. These explanatory variables 
help determine under what conditions the original relationship 
is strong or weak. In a pre-post nonexperimental design in 
which causal attributions are inappropriate, the reliance on 
statistical controls for a reasonable explanation of the 
results depends on specifying the effects under different 
conditions. 
Table 6 below presents the distribution of subjects by 
drug of abuse and drug using outcomes at follo\\\lp. 
TABLE 6 
DRUG OF ABUSE BY DRUG USE 
AT FOLLOWUP 
Preinduction 









28% of the expected cell 
X2=14.22 df=6 P=.0272 
Using Drugs at Followup 
(N=97 ) 
No Yes Total 
13 11 25 
3 14 18 
1 2 4 
11 2 13 
8 5 13 
9 13 22 
1 4 6 
47% 53% 100% 
(N=46) (N=51) 
frequencies are less than 5.0. 
% 
Table 6 indicates that the type of preinduction drug of abuse 
has a significant relationship to drug lise at followup. While, 
for example, both heroin and methadone were heavily represented 
in the research population, many more patients addicted 
to heroin were reported as non-drug-using at followup. 
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It has long been assumed that the type of drug a pati.ent is 
adClfcte<l. -to may influence his chances of recovery. In the following 
____ .. ________ pa.g.e.s-,-t.he- pr e i nd u c t i·on d-ru·g of --a·dd.i"c-t ionTsrera-tect- to dru g-use-------
at outcome. These relationships are necessarily limited lacking, 
for example, an interplay in po1y-d_rug abuse. Table 7 below 
is a comparison of drug use at follo\'4lp collapsed into two major 
classes of drugs: opioid and nonopioid (in this instance nonopioid 
refers to cocaine). 
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Table 7 above shows that those in the research population who 
entered treatment as opioid addicts were significantly more likely 
to be readdicted at follo\\Up than those who entered primarily using 
cocaine. This finding could relate to the greater physiological 
addictiveness of opi01ds or indicate that perhaps the drug abuse 
treatment received by the research popul at ion worked better for 
cocaine addicts. To further clarify these results 1t is necessary 
to determine if there were additional contributing factors. 
Cocaine appears to be a drug used by a broad social economic 
status group when compared to heroin and methadone. Table 8 shows 
the same relationship controlling for the patients' annual income. 
In this three-variable analysis one should not expect income, (when 
inspecting the relative proportions) even with a larger population, 
to have any effect on outcome. Even in a correlation analysis 
income alone did not predict drug use severity ou tcome; opioid 
addicts were therefore significantly more likely to be readdicted 
at followup than cocaine addicts. 
Op10ids in th1s study, include heroin, methadone, codeine and 
dilaudid. Heroin and methadone are the most prevalent and also will 
be examined here due to the longstanding assumption that methadone 
addiction is more difficult to treat successfully then heroin addiction. 
However, in clin1cal circles, this assumption is made because of 
methadone's longer detox period, i.e., methadone renains in the body 
TARLE 8 
OPIOIDS AND COCAINE BY DRUG USE AT FOLLOWUP: CONTROLLING FOR INCOME 
N=92 
. 
Opioid s Cocaine 
Us ing Drugs 
at Follo'tAJp *Lo Income Hi Income Lo Income Hi 
No 40 44 No 75 
Yes 60 56 Yes 25 
100% 100% 100% (N=35) (N=45 ) (N=80) (N=4) 
*Lo Income = < 20,000 




100% (N=8 ); (N=12) 
\ 
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tissues longer than heroin and is associated with depression. 
The heroin addict often can be completely detoxified in 5 to 8 
days, whereas a methadone addict might take from 8 to 14 days 
for a complete detoxification. 







HEROIN AND METHADONE BY DRUG USE 













The above presentation indicates that heroin addicts in the research 
population were significantly more likely to be drug-free at follow-
up than were methadone add icts. 
-_ ... -._- - ._--- -. 
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Another drug of abuse that has become quite popular among 
drug aoosers is speedballing. tha"t __ !~_._"lDtt:'av."enou"s]'y-adm-i.n-i-s-ter-i"ng"--
a mixture of both heroin and cocaine. The comparison below. Table 
10. is of drug-using outcomes cross-tabulated with cocaine and 
speedball . 
Using Drugs 


















In Table 10 speedball users were significantly more likely to be 
readdicted at followup than cocaine users; further analysis is 
not warranted due to the small N. 
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Treatment Process Variables 
The treatment process variable that best predicted outcome in 
the research population was whether or not a patient entered the 
outpatient program. Table 11 below illustrates drug-using outcome 
compared with entry into the outpatient program. 
TABLE 11 
OUTPATIENT PROGRAM PARTICIPATION 
BY DRUG USE AT FOLLOWUP 
(N=97 ) 
Entered Outpatient Program 
Using Drugs 
at Follo\\Up No Yes 
No 35 59 
Yes 65 41 
100% 100% 
(N=46) (N=51) 
X2=5.60 df=1 P=.0179 Phi=.24 
Table 11 indicates that 51 of 97 patients entered the 
outpatient program. Here, it is clear that those who entered 
the outpatient program were significantly more likely to be drug-
free at followup than those who did not enter. This finding is 
supported by a Pearson correlation coefficient with slightly 
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different variables. The variables in th~ correlation analysis 
are length of stay in the outpatient program and post-drug severity 
--- ------- ------------In ottl-er- -words, --the longer a 
patient stayed in the outpatient program the lower the post-drug 
severity rating was at followup (r=-.31, P<.05, N=64). These 
findings must be interpreted with caution because it is not clear 
why some patients stayed in treatment longer than others (a self 
selection bias may have been operating). 
In view of the fact that outpatient program attendance and 
length of attendance were related directly to positive followup 
outcomes, a logical next step at this point was to isolate other 
variables related to participation and length of stay in the 
hospital·s outpatient program. As stated previously, those patients 
in the research population who successfully completed the inpatient 
treatment protocol were allowed to enter the outpatient program. 
Twenty-seven of 101 patients did not successfully complete the 
inpatient program and only 3 of 27 entered the outpatient 
program;* of the 74 who successfully completed the inpati.ent 
program, 48 actually entered the outpatient program. Thus, 
a 1 though compl et ion of the inpati ent program was not rel ated 
directly to drug use at followup. it was linked directly to 
outpatient program participation. and. through this linkage, to 
significantly lower drug-use severity ratings at followup on the 
ASI. Table 12 shows graphically the inpatient program-outpatient 
program relationship: 
*The three exceptions were granted a waiver by the hospital adminis-








INPATIENT PROGRAM COMPLETION 
BY OUTPATIENT PROGRAM PARTICIPATION (N=101 ) 




100% 100% (N=27 ) (N=74 ) 
P<.000l Phi=.48 
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Table 12 shows that those who successfully completed the 
inpatient program were significantly more likely to go into the 
outpatient program than those who did not successfully complete. One 
might add that length of stay in the inpatient treatment protocol 
significantly correlated with completing the program at an r=.32 
(P<.05, N=64), but it did not directly predict outcome. 
The next variable, referral source, when subdivided into health 
professional or self-referral, predicted successful completion of 
the inpatient program. Here, a health professional referred to 
professionals such as a psychiatrist or other M.D., an employment 
assistance program counselor, social worker or drug counselor. 





TABLE 13 . 
REFERRAL SOURCE BY INPATIENT PROGRAM COMPLETION 
(N=90) 
Referral Source 
Health Professional Self-Referred 
No 18 40 
Yes 82 60 
100% 100% 
(N=55) (N=35 ) 
df=1 P=.0225 Phi=.24 
The data portrayed i.n Table 13 suggest that, contrary to 
long-held bel iefs in this field, patients who are referred by a 
health professional are significantly more likely to complete the 
inpatient program than those who are self-~eferred. This result 
may be explained in treatment canpliance or practice terms, that 
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is, if the referral was from a health professional, the patient 
may have had more experience in treatment process and may have been 
consequently more compliant with program demands. One might also 
tentatively conclude that the motivational level may have been 
different--with the health-professional--referred patient more 
f 
motivated to succeed both because of support from the professional 
and the patients prevfously demonstrated desire for help. This 
result is surprising because of the previous widespread belief 
that self referrals were more motivated for success in treatment. 
It was shown in Table 12, that a patient who successfully 
completed the inpatient program was significantly more likely 
to go into the hospital's outpatient program than a patient who 
did not complete the inpatient program. Too, if a patient entered 
the outpatfent program, he was signfficantly more likely to be 
drug-free at followup than those who did not enter the outpatient 
program. The analysis performed to show these relationships 
primarily used dfchotomous variables of entry or non-entry into 
the outpatient program and completion or noncompletion of the 
inpatient program. The drug-using outcome measure referred to 
readdictive levels of drug use or non-drug use. 
To gain further insight into these relationships other 
measurements will be used here that are suitable for multiple 
regression analysis. Thus, the independent variables employed are 
length of stay as inpatient, completion of the inpatient program, 
and length of stay as outpatient; the dependent variable is post-
treatment drug use severity assessed on the ASI. Table 14 
displays these variables: 
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TABLE 14 
TREATMENT PROCESS PARTICIPATION AND DRUG USE 
SEVERITY AT FOLLOWUP 
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--- -- ---- (N=64)----- ------ ----------------- ------ ----- -




Varia bl es r 
-
Length of stay as -.19 
inpatient 
Completion of -.27 
program 
Length of stay as 
-.31 
outpat ient 
*Values, 0 = did not complete. 
1 = compl eted. 
R R2 Beta 
.19 .04 -.10 
.30 .09 -.13* 
.35 .12 -.22 
Table 14 is a hierarchical regression analysis and the 
variables used in comi>ination account for 12 percent of the outcome 
variance. r~odest as the result may be, it nevertheless supports 
the notion that the more treatment a member of the research 
population received at the hospital, the more likely he was to 
have a lower post-treatment drug-use severity rating at follo\\Up. 
Table 14 indicates that length of stay as an inpatient did not 
contribute much to understanding the outcome variance. This 
might have been due to length of stay and completed program 
sharing variance. Moreover these results indicate that more of 
the outcome variance is explained with the addition of treatment 
process variables. Furthermore, the variable length of stay as 
outpatient contributed most to the explanation of the drug use 
severity outcome variance. 
Summary. In reviewing the variables covered thus far, one 
can state with confidence that the composition of the research 
population was different from the drug-addicted populations 
that generally have been researched. White upper class addicts 
with a high education level and high income characterized this 
research population. An antecedent factor related to followup 
outcome was the preinduction drug of abuse in that type of drug 
significantly affected drug use at outcome. Methadone addiction, 
in this research population, was more difficult to treat success-
fully than heroin or cocaine addiction. Note that economic or 
other covariant factors did not playa role in these particular 
findings. 
Table 13 suggested that those patients referred to the 
hospital by a health professional were significantly more likely 
to have successfully completed the two-month inpatient treatment 
program than those who were self referrals. Motivation or practice 
effects were considered salient factors in this Case. One should 
note also that the sixty-four patients in the research population 
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who were contacted at followup were more likely to be drug-free 
than-- other menbers of the research population. This result 
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--- ----- - -- ---- --con·f-or-med--to·-find ings tn·-the -1 iterature and-'may-hav·e·-related-to·---------- ----- ---
stability in living arrangenents or, for example, merely, to desire 
by the patient to be contacted. Overall, the research population 
was successful on a three-and-a-half month followup outcome with 
46 percent of the patients renaining drug-free. Resnick, Washton 
and Rawson, (1979) reported a 30 percent success rate (that is, 
drug free) at a six month followup from intake. 
Based on the data discussed thus far, an observer might 
reasonably conclude that the more treatment a patient receiv~ 
the better were his chances of being drug-free at followup. 
Successful completion of the inpatient protocol was, in fact, 
linked to lower folloWlJp drug use severity rating on the AS!. 
Among the treatment process variables, entering the outpatient 
program and length of stay in the outpatient program had the most 
significant effect on followup outcome. Length of stay in the 
outpatient program might have been the variable that was most 
indictive of the patients' motivation for treatment, for there 
was no obvious external motivating force to keep them in treatment 
as in the inpatient protocol. As stated previously, inpatients 
were required to give seventy-two hours notice before being allowed 
to 1 eave. 
Finally, while this hospital attracted an atypical population, 
thus making comparisons to other treatment programs inappropriate, 
it had a superior success rate when compared to other populations 
TABLE 15 
TREATMENT PROCESS RESULTS 
Entrance into Inpatient Program 
N=101 
Length of Stay Inpatient 
54 days 
Range 6 to 160 days 
Completed Inpatient 
N=74 
Did not Complete Inpatient 
N=27 
Entered au tpat i ent 
N=51 
Length of Stay OUtpatient 
69 days 
Range 1 to 160 days 
Followup Length 
104 days 
Range 68 to 226 days 













in the available literature. Table 15 summarizes the treatment 
process resul ts. 
---- -----
Critical Periods Analysis 
As pointed out on page 7. Kleinman and lukoff (1980) identified 
two critical periods in the lives of addicts--times which. they 
hypothesized. are crucial to predicting drug-abuse treatment outcome. 
The first critical period preceded entry into treatment and the 
contributing variables are employment status. crime rate, and 
marital status. The second critical period occurs in the late adoles-
cence and the relevant variables are age of addiction. age of first 
arrest and years of edu·cation compl eted . 
In this section the present results are viewed in terms of how 
they support just-mentioned "two critical periods" fonnulation of 
Kleinman and lukoff. The assessment of the data's relevance to the 
first cr it ica 1 period hypothes i.s wi 11 proceed in terms of -1) econom ic 
support status (treated as equivalent to Kleiman and lukoff's 
employment status), 2} legal severity (equivalent to their crime 
rate, and 3) marital status, the d.iscussion of which, however, will 
be deferred to the section on Natural Support Systems (see p. 87). 
I . 
The assessment of the data's relevance to the second critical period 
hypothesis will proceed in terms of 1) age of first arrest, 2) age 
of drug use onset (equivalent to age of addiction), and 3) years of 
education. In the course of these assessments a few other factors 
and their correlation with the factors of primary concern wi.11 be 
considered. 
Economic support status--an ASI rating of income, job-holding 
ability and training for a profession, trade, or ski11--is pertinent 
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to Lukoff ' s truncated socialization hypothesis (see Chapter 1, page 8) . 
If, for example, a patient's first arrest was early in life, then his 
abil ity to achieve a well-developed economic support status is more 
than likely questionable. The same holds true for conjugal relation-
sh"ips: the more criminal or drug-abuse history in a patient's past, 
the less likely he will have a conjugal relationship. 
Legal severity was measured by the ASI (see Appendix C-3) 
and correlated with the ASI drug-use severity rating at followup. 
The variables that predict post-treatment drug use severity outcomes 
directly as measured by the ASI (A post-treatment drug use severity 
treabnent need rating) are, legal severity, i.e. the higher the 
patients legal severity, the greater is his post drug use severity 
rating. This finding was expressed in a significant (P<.05) 
Pearson correlation coefficient where r = .31, and 
N = 64. 
The number of previous trea'bnent episodes also correlates 
significantly with higher drug-use severity rating at followup 
with a correlation of r = .28, which is also significant (again, 
N = 64, P<.05). Completing the program (a dichotomous variable 
where 0 = did not comp1 ete and 1 = successfully compl eted program) 
correlated with r = -.26 with drug-use severity at fo1lowup which 
73 
was significant (still. N = 64, P<.05). 
The age at first treatment contact significantl y correla ted--
- -- ---" -----r-=---.-32-(-N-=- 95, P<.05)- wtth -the--h-urtlber- of--treatmenl- ep-isocfes-and ------- - --
larger number of treatment episodes correlated with earl ier onset of 
regular drug use. The earl ier age of treatment contact did relate 
d irectl y to more drug treatment probl ems 1 ater . 
The next hypothesis tested was that the earlier the age at 
first arrest, for any charge. the less likely it was that a patient 
would successfully compl ete the inpatient treatment protocol. In 
a Pearson correlation analYSiS, the age at first arrest significantly 
correlated as r = -.29 (N = 95. P< .05) with completing the program. 
As stated previously, the earlier the age of first arrest, the more 
truncated the patient's socialization was likely to have been and 
the less likely he was to have completed the treatment program 
leading to a high drug-use severity rating on the AS!. 
Table 16 is a hierarchical multipie regression using the 
dependent variable of drug-use severity at followup: 
Table 16 indicates a modest amount of variance and shows that 
the variable "compl eted program" significantly added to the outcome 
variance expla ined. This modest resul t may have been due to two 
factors: first, the measures themselves can be questioned regarding 
measurement error; second. the research population was a sel ect group 
and tended toward homogeneity. thereby yielding lower amounts of 
explained variance. Age at first arrest alone did not directly 
account for a n important amount of outcome variance; however, 
age at first arrest together with completed program signifi-
cantly affected the outcome variance. Moreover, Table 16 
illustrates that the earlier the age of first arrest and onset 
of drug abuse did, to some extent, influence compliance with, and 
completion of, the inpatient program. Therefore, earlier age at 
first arrest and drug abuse suggested a behavioral nonconformity 
that affected treatment compliance and, in turn. affected drug-use 
outcome at followup. This finding agreed with Lukoff's work 
mentioned previously here and in Chapter 2. The earlier the 
age of drug-use onset, the earlier the subject's first treatment 
contact, the earlier the age of first arrest, then the less likely 
the patients in the research population were to complete the 
inpatient program and, therefore. the more likely they were to 
have had a higher drug-use severity rating at followup. 
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TABLE 16 75 
HIERARCHICAL r-mLTIPLE REGRESSION ANALYSIS OF AGE OF ONSET. OF DRUG USE 
TREJlTMENT CO~TACT, FIRST ARREST, AND PROGRAM COMPLETION BY DRu(; LISE 
___________ _ ______ __ _____________ __ _SEVER!T~{~~3~~LLq~~~-------- _______ --
Drug-Use Severity at Foll OWlJp (ASI) 
Hierarchical Order 
R2 of Independent Variables r R Beta 
- -
Age of onset of .05 .05 .01 .28 
drug use 
Age of first -.08 .11 .01 -.02 
treatment contact 
Age of first arrest -.06 .15 .02 -.30 
Com p 1 eted program -.42 .50 .25 -.52* 
*Sig. P<.05 
Al though the low N 1 imits the strength of- this analysis, obta ining a 
significant increase in explained variance and accounting for 25 
percent of the outcome variance indicates a stable and robust 
relationship. 
The legal severity rating on the ASI significantly correlated 
(Pearson r = .37 at P<.OS, N = 62) with economic support status 
severity, implying that the more legal severity, the higher the 
economic support status severity. Legal severity significantly 




HIERARCHICAL MULTIPLE REGRESSION ANALYSIS OF ECONOMIC AND LEGAL SEVERITY 
BY DRUG USE SEVERITY AT FOLLOWUP (N=62) 
Drug-Use Severity at Followup (ASI) 
Hierarchical Order R2 of Independent Variabl es r R Beta 
-
Economic support .18 .18 .03 .10 
status severity 
Legal severity .32 .33 .11 .29* 
*Sig. P<.OS 
Economic support status and legal severity in Table 17 account 
for 11 percent of the drug-use severity outcome variance at follo\\\lp 
among the research population. Although this is a small amount of 
variance explained, it is noteworthy because of the relationship 
between poor economic support status and greater 1 ega 1 severity, 
resulting in a higher drug-use severity rating at follo\\\lp. 
Previously, treatment compliance was shown to significantly 
affect outcome to the extent that if a patient in the research population 
successfully completed the inpatient program and entered the outpatient 
program, he was significantly more likely to be drug-free at followup. 





.---- _. -----_. -- _. - ------- -------
TABLE 18 
PROFESSION. TRADE OR SKILL BY ENTRY 
INTO OUTPATIENT PROGPAM (N=101) 
Profession, Trade or Skill 
No Yes 
No 68 43 
Yes 32 57 
100 % 100% 
(N=25) (N=76) 
X2=4.55 df=l P=.0330 Phi=.21 
Table 18 shows that a patient with a profession. trade or skill 
was significantly more likely to enter the outpatient program than 
were those patients who claimed no profession. trade or skill. Thus, 
if a patient did have a profession. trade or skill he was likely to 
have partie i pated and complied with some form of tra ining either 
through education or on-the-job training. Those who had not achieved 
this level of socialization may not have had the capacity to comply 
with programmatic rules and regulations, thereby increasing the 
probabil ity that they would not compl ete the program and thus would 
be readdicted at followup. 
Table 19 below includes years of education, age of first 
treatment contact, number of prev ious treatment episod es and 1 ega 1 
sever ity as independent variabl es, using the drug-use severity 
rating at followup {ASI rating} as the dependent variable: 
TABLE 19 
HIERARCHICAL MULTIPLE REGRESSION ANALYSIS OF EDUCATION AGE 
OF FIRST TREATMENT CONTACT, NUMBER OF TREATMENT EPISODES 
AND LEGAL SEVERITY BY DRUG USE SEVERITY AT FOLLOWUP (N=62) 
Drug Use Severity at Followup (ASI) 
Hierarc hica 1 
Order of 
Inae~endent 
Variables r R R2 
-
Educational -.02 .02 .00 
level 
Age of first -.11 .12 .01 
treatment contact 







Legal severity .34 .41 .17 .31* 
*Sig. P<.05 
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Table 19 indicates that education does not add to this 
explanat-ion. This result may have occurred becaus-e of the 
----- ----- ----- -- .- -
narr·aw-range-- edu cation has·_·'-n--ihe-study- pOPul ation. However, 
the earlier age of first treatment contact leads to more treatment 
episodes, and greater legal severity. Together. these factors 
relate directly to drug use severity at follolrAlp. Furthermore. 
these data seem to indicate that the more prior drug-abuse treat-
ment episodes. the more likely the patient is to be readdicted or 
have higher levels of drug-use severity at folloWJp. 
The preceding table seems to indicate that the earlier the 
age of drug treatment onset within the research population. the 
more truncated the socialization (more treatment episodes and 
legal problems). and the less likely to successfully finish the 
inpatient treatment program. consequently yielding higher drug-use 
severity ratings at follolrAlp. 
In summary these data support the critical periods theory of 
Kleinman and lukoff (1980). This analysis indicated that employ-
ment status, criminal involvement and support through a conjugal 
relationship affected treatment outcome either directly or in 
combination with treatment process variables. 
The second critical period in the lives of drug addicts 
according to the above researchers encompasses age of first drug-
abuse treatment contact and age of first arrest. These data 
also support the truncated socialization hypothesis lukoff (1974). 
Here, the earlier any of the above deviant behavior patterns 
occurs the more profound became the rel ated behav ioral 
probl ems. 
Dominant Treatment Process Variables 
At this point in the examination of the research data, it is 
appropriate to single out treatment variables which have seemed to 
be of central importance to the goal of this study, namely, to 
evaluate the drug-abuse treatment program. The variabl es are 
the following: 
a. length of stay in the inpatient program; 
b. whether or not the patient successfully completed 
the inpatient program; 
c. length of stay in the wtpatient program and/or 
whether they entered the outpatient program. 




- --_.-_.---------- ---- -- --
HIERARCHICAL MULTIPLE REGRESSION OF TREATMENT 
PROCESS PARTICIPATION AND DRUG USE 








R2 Variabl es r R Beta 
-
Length of stay 
- .19 .19 .04 -.10 
inpatient 
Completed program 
-.27 .30 .09 -.13 
Length of stay 
-.31 .35 .12 -.22 
outpa t i ent 
Although Table 20 relates only to the patients in the research 
population who were contacted directly. there seem to be connections 
here worth noting. It appears that the patient who went furtherest 
in the treatment process increased their changes for a positive 
outcome at followup. This, of course. would be a logical goal of 
any treatment fac 11 1ty: the more trea tment received. the more 11 kely 
the patient is to achieve a positive outcome at followup. In the case 
of this study population, the resul t gives some credence to th.e 
notion that the drug-abuse treatment program may have been 
helpful. However these results may say very little about the 
efficacy of the treatment program. Instead patient selection 
bias may be operating, that is. the patient who goes further in 
the program could be the type of patient that is more likely to 
be drug free at followup. There can be no conclusions reached. 
regarding this issue because the research design is not adequate 
to answer this question. 
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An assumption discussed previously is that a pati.ent arrested 
prior to first drug use is more likely to first have been arrested 
for a nonnarcotic charge. Nevertheless. in all likelihood he 
became involved with drugs through association with the illegal 
drug distribution system. If first arrest followed onset of 
regular drug use. the charge was most likely narcotic. Table 21 
illustrates whether first arrest in the research population was 
narcotic or nonnarcotic: 
------- - - --------
TABLE 21 
TYPE OF CHARGE AT FIRST ARREST (N=10l) __ _ __ - .--













Table 22 compares charge at first arrest and whether drug use 
started before or after first arrest: 
TABLE 22 
CHARGE AT FIRST ARREST BY DRUG USE 
PRE- AND POST- FIRST ARREST 
(N=66) 
. Drug use pr ior 















Table 22 indicates that the patients first arrested on a 
narcotic charge were significantly more likely to have 
started their drug use prior to first arrest. This result 
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suggests that the patient arrested pr1.or to first drug use may have 
been involved in a criminal life style prior to their drug abuse. 
Natural Support Networks 
Natural support networks are relevant to this discussion because 
they help to predict treatment process variables (completing the in-
patient program and entering the outpatient program) which, in turn, 
are useful in predicting outcome. It has been assumed that, if a 
patient was involved in a conjugal relationship, he would be more 
motivated and compliant than a patient who was not involved in such a 
relationship. Thirty-one patients in the research population reported 
that they were married and seventy reported being unmarried or divorced. 
This classification unto itself did not significantly influence comple-
tion of the inpatient program, nor does it significantly relate to 
entering the outpatient program, or forecast drug-using behavior at 
followup. 
Furthermore, conjugal associations or lack of same did not 
significantly influence program completion, outpatient participation 
or drug use at follow.ap. However, when evaluating the estimated level 
of support within the conjugal dyad, a different story emerged. In 
Pearson correlations using, as the predictor, estimated level of 
support of the conjugal mate on a Likert-type scale rating the 
estimated 1 eve1 of sU,pport of the patient's abstinence and treat-
----=---; -- -- - -----' 
---- ------ment-(-s'ee-T-abl e 23) s ignificant-r-el ationsh"ips were found with 
program completion, outpatient participation and drug use at 
foll owu p. 
TABLE 23 
LIKERT TYPE SCALE 
Estimated Level of Support of the Patients Treatment 












Note that a -2 (attempt to sabotage) rating was also applied 
when there was a drug-using conjugal mate; "not supportive" means 
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no interest in the patient's abstinence or treatment, "supportive" 
and "very supportive" imply an effort and concern for the well-being 
of the drug-addicted mate. 
The support level of the conjugal dyad significantly correlated, 
r =.17 (N = 95, P<.05), with completion of the inpatient program. 
Completing the inpatient program significantly correlated at r = .38 
(N = 95, P<.05) with length of stay in the outpatient program, 
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correlated in turn. with r = -.31 (N = 64. J><.05). with d~ug-use 
severity at followup. Although a multiple regression was performed 
with these variables. the outcome explanation was slight and the 
variance explained was not significant with an R2 equalling .126 
percent. However. estimated level of support as shown in Table 24 
contributes to the explained vadance at outcome. 
Table 24 is a Hierarchical Regression presentation of the 
aforementioned variables: 
TABLE 24 
HIERARCHICAL MULTIPLE REGRESSION LEVEL OF SUPPORT 
OF THE CONJUGAL DYAD AND TREATMENT PROCESS 
VARIABLES BY DRUG USE SEVERITY AT FOLLOWUP (N=64) 
Drug Use Severity Rating at Followup (AS!) 
Hi erarc hica 1 
order of R2 Independent Variables r R Beta 
-
Est imated 1 evel 
-.16 .16 .02 -.07 
of support 
conjuga 1 dyad 
Length of stay 
-.19 .23 .06 -.10 
inpatient 
Compl eted program 
-.27 .31 .09 - .12 
Length of stay 
-.31 .36 .13 -.21 
outpatient 
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Although Table 24'does not yield a significan~ expl~nation of 
the drug-use severity outcome at followup. all indications in the 
-- - --------r'es-earch-p-o-pula t ion were thaf a su pportive conjugal mate enhanced 
the patient's chances of completing the inpatient program. Conse-
quently. this fact increased the probabil ity that the patient 
entered the outpatient program and achieved a more favorable followup 
outcome than a patient without a supportive conjugal mate. 
Another natural support network variable was seen in the 
examination of treatment process and outcane in the research 
population. A tally of drug-using friends significantly correlated (N=53, 
P <.05) at r = .37 with length of stay as an inpatient which. in 
turn. significantly correlated with completing the program. This 
latter variable significantly correlated with both length of stay as 
outpatient and drug-use severity at followup. 
This linkage is striking because a higher frequency of drug-
using friends in a patient's natural support network might have 
encouraged him to remain in treatment longer. This may have been 
because the patient (and/or the parents of the patient or staff members) 
knew that his friends' influence would be deleterious to his abstinence, 
so that the patient remained longer in the inpatient program. 
It is characteristic of the group having drug-using friends 
that they were mostly male. Also the data indicate that these 
patients had a larger number of relatives in the network and may 
have been 1 iv i ng at home. 
The point is that drug-using friends significantly correlated 
with the patient remaining longer in treatment. And. tbe pati.ent's 
prospects for a favorable outcome at followup were improved 
correspondingly. Staying in treatment longer yields better 
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followup outcomes insofar as the research data were concerned. These 
variable relationships are shown below 1n a multiple regression 
analysis. 
TABLE 25 
HIERARCHICAL MULTIPLE REGRESSION OF DRUG USING FRIENDS 
AND TREATMENT PROCESS VARIABLES BY DRUG USE SEVERITY AT FOLLOWUP 
(N=35) 
Drug Use Severity at Followup (AS!) 
Hi erarc h ica 1 
Order of 
Independent Variables r R R2 Beta 
- -
Drug using friends - .13 .13 .02 .02 
Length of stay 
-.22 .23 .05 .21 
inpatient 
Campl eting -.02 .23 .05 .23 
inpatient program 
Length of stay 
-.28 .37 .14 .35 
outpa tient 
As seen in Table 20, length of stay in treatment, completing 
the inpatient program and 1 ength of stay as outpatient accounted 
for .12 percent variance of drug-use severity at followup. The 
addition of drug-using friends brought the amount of explained 
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variance up to .139 = .14 percent. While not a significa~t contribu-
tor to understanding of the outcome variance. the relationship sheds 
----- ------- .-. 
----- ------------
-------- ----s-Oine l1gnfOfldrug-use severity at followup. 
As for the existence of age-mate friends in the support network 
opposed to those patients in the research population claiming no 
friends. Table 26 compares the existance of age-mate friends with 






AGE-MATE FRIENDS BY ENTRY 














As can be seen above. those patients with age-mate friends were 
more likely to enter the outpatient program than those patients with no 
friends. Since patients with age-mate friends were significantly 
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more likely to enter the outpatient program, they were therefore more 
likely to be drug-free at followup. 
The presence of age mate friends may indicate greater social 
responsiveness and as a result. a greater degree of treatment 
compliance. 
SUmmary. In summarizing the data presented in Tables 16 
through 26, one can say that they tended to support both lukoff's 
truncated socialization hypothesis and the critical periods thesis 
promoted by Kleinman and lukoff. For example. the data indicate that 
employment status. criminal involvement and estimated level of support 
in a conjugal relationship affect treatment outcome separately or in 
combination. Age at addiction and age of first arrest also influence 
treatment outcome according to these data. The frequency of past 
drug-abuse treatment contacts also may be an indicator of past 
drug-use history according to the data. 
The treatment implications of these variables and their relation-
ship to treatment outcome strongly supports the establishment of 
adolescent-directed prevention and awareness programs or other early 
intervention strategies. Conjugal associations and age-mate friend 
networks (either drug-using or not) also support social work treat-
ment efforts emphasizing engendering conjugal support or separation 
from a conjugal mate who attempts to sabotoge a patient's drug-abuse 
treatment and drug-use abstinence. 
- -- -- - ---------_. 
Pre-Post Residualized Change 
Score Analysis 
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The residualized analysis is suggested by Cohen and Cohen (1975) 
where they say lithe simpl e ga in score is not adequate in the analysis 
of change. The problem 1 ies in their necessary dependence on pre-
scores and this incurs a liability of low reliability. Residualized 
change scores are computed by partfa Hzing one varia bl e from another 
and thereby producing a residual variable from wh.ich you compute 
change. 1I 
The residualized change score approach makes sense because 
people are relatively consistent over timei therefore, the correlation 
relations between pre- and post-scores needs to be divided by the 
standard deviation--yielding the amount of variance that corrects for 
the amount of change which cannot be contributed to the inherent 
correlation between pre-and post measures. 
The seven life areas assessed pre- and post-inpatient treatment 
on the ASI are: medical severity, economic support status severity. 
alcohol severity. drug severity, legal severity. family social severity 
and psychiatric severity. 
TABLE 27 
RESIDUALIZED CHANGE SCORES* 
BETWEEN THE PRE- AND POST-ADMINISTRATION 
OF THE ASI {N=64 } 
Residualized Change Scores 
Variable R R2 B F llq. 
Medical Severity 0.17 0.03 0.25 1.93 NS. 
Economic Support 0.27 0.07 0.30 4.77 Si9·* 
Status Severity 
Legal Sever i ty 0.44 0.19 0.75 14.85 Sig.* 
Fam il y Soc ial 0.29 0.08 0.19 5.41 Si9·* 
Severity 
Alcohol Severity 0.36 0.13 0.96 9.29 Sig.* 
Drug Sever ity 0.03 0.00 0.16 0.05 NS. 
Psychiatric Severity 0.11 0.01 0.79 0.79 NS. 
*(1'<.05) 
Formula: rbc = rb (a-b) = rab sda - sdb 
...; sd 2 + sd 2 - 2r sd sd 
a b ab a b 
( Cohen 1975) 
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Six month assessments using residualized change 
score analysis in four of the seven problem areas assessed 
-- ------- ----
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- ----------on-t"WeASI-stiowed significant and pervasive improvements in most 
patients relative to their admission status. 
The residualized change score analysis Table 27 shows that 
pre-post medical severity did not change significantly; this is not 
unusual since longstanding medical problems usually are not amenable 
to change in a six-month period. Economic support status severity. 
however. did change significantly pre- and post- as did alcohol 
severity, legal severity and family social severity--all variables 
related to a drug-using lifestyle. However, drug severity pre- and 
post- did not change significantly, nor did psychiatric severity. 
Summary. This analysis showed that diffused treatment goals 
might indeed have impacted significantly on the 1 ife of the patient, 
but not on drug abu se, moo i calor psychiatric probl ems. These 
various aspects of change (that is, outcome) were not interrelated 
with other measures. Therefore, the simple assumption that drug use 
caused problems in other areas of living was overstated in terms of 
these findings. 
These results suggest that when diffUsed treatment goals 
built into the treatment program create a lack of tailoring to 
particular needs of the individual, the result m.ay cause no change 
in drug abuse and psychological areas, which are the two major 
foci of the program (Lukoff Personal Communication ~983). 
The introduction of different facets of treatment should 
have contributed to positive outcomes within the research 
population, and, indeed, they did. However, they were 
limited to specific behavior within a life area, not associated 
directly with drug-using behavior. 
In other words, change took place but it was not tied, 
via a one-to-one relationship, to drug-using behaviors. Therefore, 
an assumption of a simple relationship between these life areas 
and drug-taking behavior was invalid in this scheme. 
Psychotropic Medication 
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When an opioid addict is detoxified, the patient theoretically 
can return to the community where opioid-free rehabilitation in the 
form of behavioral and psychosocial therapeutic support can be 
administered on an outpatient basis despite a critical adjustment 
period and the availability of illegal drugs. A theoretical basis 
for opioid-antagonist treatment was developed by Wikler (1965, 1973) 
who suggested that conditioning factors of which neither the therapist 
nor the patient are aware may be responsible for relapse to opioid 
use in detoxified addicts. 
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Basing his argument on principles of operant and Pavlovian 
-----_. 
-c-oncrft-iorffng. Wi kl er proposecr a two-factor learning theory of relaps ing 
behavior. namely. that through the process of operant conditioning the 
rel ief from emotional and physical distress provided by an injection of 
heroin constitutes a powerful reinforcement that can establish and maintain 
opi oi d-using behavi or (See,., Chapter., 2. page, .. 21). In addition, through . 
.... , ' 
repeated pairings between stimuli in the addict's environment, withdrawal 
symptorr.:;, and their relief, Pavlovian conditioning comes into play 
causing a craving for heroin in the previously d'etoxified addict when 
he contacts these same environmental stimuli. As a result,this 
so-called conditioned-abstinence response can provoke the detoxified 
addict into reinitiating opioid use and. consequently. relapsing into 
opioid addiction. This emotionally induced craving may reflect a 
physiological state of arousal in turn triggered by physical or 
emotional discomfort that the addict experiences,a~pa~t of his drug-
free community re-entry perjod. 
According to this particular model, when opioid-reinforcing 
properties are blocked by the opioid antagonist. drug-seeking behavior 
will Cease because previously conditioned responses are extinguished 
(Resnick, 1979). Resnick asserts that conditioning factors may 
explain why detoxification treatments without pharmacological supports 
generally have not been successful. 
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It may be possible that a family of pharmacological supports 
is effective in this paradigm depending upon precise circumstances. 
For example, if the conditioned-abstinence response is, in fact, 
IIstate dependent,1I then a pharmacological therapy that alters the 
state of the patient also may lead to the extinction of the condition-
ed-abstinence response. For example, administering a mood-stabilizing 
psychotropic medication to the patient during drug-free reentry into 
the community may block or partially deflect the conditioned abstinence 
response because of earlier intervention in the readdictive two-factor-
theory process (when the state of arousal caused by emotional and/or 
physical discomfort occurs) then the behavioral reaction to the 
conditioned environmental stimuli of getting high would be less 
attractive and thus have a reduced impact on the addict. 
In discussing the conditioned-abstinence response Resnick and 
others have suggested that for some addicts the incentive for seeking 
and using opioids is physical or emotional distress comparable to 
psychiatric symptoms. Thus, if the addict is self-medicating psychia-
tric symptoms, then removing the incentive for seeking and using 
opioids is to preclude the appearance of the symptoms. Emotional 
lability and distress are acute in the community reentry phase of 
treatment for the detoxified addict. The use of appropriate 
psychotropiC medication may stabilize the addict's emotional balance 
and extinguish the conditioned-abstinence response. PsychotropiC 
medications that achieve the above two objectives would preclude a 
patient's exposure to the reinforcing properties of opioid drugs. 
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Thus. with biochemical outpatient support, psychosocial and behavioral 
treatment techniques can be stressed in a low-risk outpatient treat-
------------- ---
precondition for successful treatment outcome. In view 
of the foregoing discussion, mood-stabilizing medication 
may be more useful with a select group of patients, namely, 
those with marked emotional labil ity or pronounced psychiatric 
symptom severity. This group may be called "crossovers" or "self-
med icators". This self-medicating class of d"rug users are those 
whose addiction may be due in part to existing psychiatric symptoms 
that are reduced by nonprescription drug administration. In the final 
analysis, however. biochemical support ~an be only an adjunct to 
psychosocial and behavioral treatment modes. 
It is appropriate to note here that the id"ea of medicating drug 
add icts. as in the case of methadone treatment, is v iewed by many 
professionals as simply changing drug dependence fran one substance 
to another. It is fair to state that generally prescribing mood-
altering medication for detoxified addicts is frowned upon by many 
professionals. Thus, there is a widespread prohibition on the use 
of psychotropic medications in drug-abuse treatment (McLella"n, 1980). 
Naltrexone has been justified to a limited extent on the grounds 
that it does not produce euphoria. The widespread contempt for 
medicating detoxified addicts in fact may account for the lack of 
studies in the literature (see Chapter 2) on other medications used" 
in the treatment process. However. if the self-medicating premise 
discussed above is viable, then the lack of supportive alternative 
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medication in the community-reentry critical period after detoxifica-
tion--is likely to result in poorer treatment outcome. Indisputably. 
the longer a patient remains drug-free while in the community, there is a 
greater chance that he will learn new. more adaptive and flexible 
coping behavior than he previously had as a drug addict. 
Psychotropic medication type. Psychotropic medications 
prescribed for the research population fell into three main 
categories: 
a. Trycycil ite antidepressants. 
b. Neuroleptics: antipsychotics for agitation 
and/or psychosis. 
c. Mono-amine-oxide inhibitors (MAOIs): Anti-
depressants for a particular type of patient. 
MAOIs require a special diet. 
In the following discussion of the 25 patients in the research 
population on psychotropic medication, 20 took Tricyclic antidepress-
ants, 3 took MAOIs and 2 took Neuroleptics. Therefore, Tricyclic 
antidepressants constituted the majority of the psychotropic 
medications prescribed during this study. 
Table 28 is a comparison of drug-using outcome among 92 
patients, 25 of whom took psychotropic medications for 1 to 2 
months after inpatient treatment and 67 of whom did not take 
psychotropic medication. Drug-using in this case means the 
patient had returned to addictive levels of drug use within 3.5 
months after discharge from inpatient treatment. 
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TABLE 28 
PSYCHOTROPIC MEDICATION BY DRUG USE 





Yes No at FollowuE 
No 76 40 
Yes 24 ....6..Q.... 
100% 10m; 
(N=25) (N=67 ) 
X2=9.28 df=l P=.0023 Phi= .32 
Table 28 above indicates that those"who received psychotropic 
medications for their reentry protocol were significantly more 
likely to be drug-free at followup than those who were not prescribed 
medications. It is important to remember that patients were on 
these med icat ions an average of one and a hal f months post-d ischarge 
from the inpatient hospital program, and none were still 
being medicated at the 3.5 month followup. In Table 28 above the 
Phi is .32, which indicates a strong relationship. Explanatory 
variables included in this presentation that further specify the 
nature of the relationship are whether or not the patient entered 
the outpatient program {for Chi. Sq. analysis} and the length of 
100 
stay in the outpatient program (for correlation and regression analysi.s). 
These above variabl es are important because entry into outpatient 







ENTRY INTO OUTPATIENT PROGRAM 
BY DRUG USE AT FOllOWUP 
( N=97) 





(N=46) (N=51 ) 
P=.0179 Phi=.24 
The result here is not as robust as the psychotropic medication 
reSUlts, as can be seen by the Phi of .24. However, this result, 
combined with the fact that if a patient was on psychotropic 
medications he was significantly more likely to be in the outpatient 
program, contributes information that prompts the question: What 
actually was responsible for the effect on drug use at followup? 
Table 30 below sheds further light on the question: 
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TABLE 30 
PSYCHOTROPIC MEDICATION BY OUTPATIENT PROGPAM PARTICIPATION 
_t~=95) ... __ - --------------




Partici~ation Yes No 
No 24 54 
Yes 76 46 
100% 100% 
(N=25) (N=70) 
X2=6.80 df=l P=.0091 Phi=.27 
Table 30 above shows that patients on psychotropic medication 
were significantly more likely to be in the outpatient program than 
those who were not. This finding is not startling since, to obtain 
prescriptions, patients usually maintained some contact with the 
outpatient program. The question still stands: Was it the outpatient 
program, psychotropic medications--or both--that accounted for the 
outcome? 
In order to gain further insight into this relationship, we 
must examine psychotropiC medication and outcome, statistically 
controlling for outpatient involvement. The following three-variable 
table, Table 31, is composed of the independent variable psychotropic 
medication, the dependent variable drug use at followup, controll ing 
TABLE 31 
PSYCHOTROPIC MEDICATION BY DRUG USE AT FOLLO~IUP: 
CONTROLLING FOR OUTPATIENT PARTIrIPATION 
(N=92) 
No Outpatient 
Psyc hotrop1c Med ication 
Using Drugs 
at F'o"oWJ(! Yes No 




(N=6) {N=35} (N=41 ) 
50% of the val id cell s hilve expected frequencies 
less than 5-0. 
Fishers Exact. NS. 
Outpatient 
Psychotropic Medication 
Us ing Drugs 















for the explanatory variable outpatient involvement. 
The presentation in the no-outpatient portion of Tabl e 31 
. ___ -_. _. __ su f_f.e~ s. f.r-om. 1 ac k 0 f su·f-f ic i ent ex pec-ted-c-eH-fr·equ-enc-i·e·s-: -- '-Th-er e-::-- -- --.- - - -- -- - -- --
fore, a Fisher exact test was performed., but did not yield a 
significant result. However, visually inspecting the relative 
proportions of those patients in the research popul ation on psycho-
tropic medication who did not enter th.e outpatient program, 67 
percent were still drug-free, while in the no-medication group 
a greater proportion were drug-using than not. At least this result 
indicated the expected direction, although this might have been due 
to chance. A logical expectation would be that a larger N in the 
drug group would yield a significant relationship between psycho-
tropic medications and non-drug-using at followup. 
The outpatient portion of Table 31 did show if a subject 
entered the outpatient program and also was on psychotropic 
medications, then he was significantly more likely to be drug-free 
at followup than an outpatient who did not receive psychotropic 
medications. This finding is robust as indicated by Cramers Phi 
of .32. These results indicate that the outpatient program alone 
was not as 1 ikely to yield a positive outcome as the combination of 
psychotropic medication and outpatient participation. At this 
point in the data presentation, an adequate explanation has yet to 
be advanced regarding the effect of outpatient and psychotropic 
medication taken both together and separately. 
In order to determine if these two variables operate in 
combi nat ion and/or separatel y, and which var iabl e contri buted most 
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to the explanation of the followup outcome, additional analysis 
was performed using a different outcome measure and measure of 
outpatient participation. Drug-use severity as a followup outcome 
measure is a ten-point need-for-treatment rating on the ASI. Drug-use 
severity ratings at followup were obtained only for those patients 
who actually completed followups. The N for drug-use severity 
in this example was 63 whereas the N for the drug-using dichotomous 
outcome in previous tables had an N of 95. It should be stressed 
here that drug using outcome information was available through 
sources other than the patient himself (see Chapter 4. page 55). 
As stated earlier, the drug-use severity rating at followup was only 
for those who were personally contacted--that is, 64 out of 101 
patients in the research population had full followups. Therefore, 
this group has a restricted range and, as shown earlier, was 
significantly more likely to be drug-free at followup than those 
who did not have com p 1 eted fo 11 owu ps. 
If a patient was stable enough to be reached at followup and 
allowed himself to be contacted, he was significantly more likely 
not to be readdicted than those who did not have, for example, 
stable addresses, telephone numbers or who were otherwise noncontact-
able. Length of stay in the outpatient program was a continuous 
variable. The third variable in this equation was a dichotomous 
variable. 
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These variables and an N of 63 satisfied the requirements-for 
the multiple-regression analysis seen in Table 32 below: 
- ------_._---
TABLE 32 
MULTIPLE-REGRESSION OF TREAT~ENT PROCESS VARIABLES 
BY DRUG USE SEVERITY AT FOLLOWUP 
Independent 
Var faD' es r 
-




Interaction 1 x 2 -.22 
*Sig. at P<.05 
*to ic hotomy 1 =med 1 ca t 1 on 
2=no-med icat ion 
(N=63) 










In this regression it can be seen, with this selective group, that 
both outpat i ent part ic 1 pation and psyc hotropic medications contri buted 
equally and significantly (*P<.05) to the explanation of the outcome 
variance. In addition, the test for interaction d1d not reveal any 
additional explanation of the outcome variance in this group. Thus, 
the lack of interaction between these variables ind1cated no 
facilitating effect. 
The original explanation has a more representative N 
and, therefore, still stands: of t~e. patients in the outpatient 
program. those who took psychotropic medications were signifi-
cantly more likely to be drug-free at followup than those 
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who did not take psychotropic medications. Both alone were obviously 
significant and important· contributi.ons to the outcome variance. The 
lack of interaction effects added important information regarding 
the understanding of this relationship in that,if there is no 
interaction effect, then other variabl es might be important 
to the understanding of these main effects. 
Since prescriptions of psychotropic medications ususally 
indicated an affective disorder, psychiatric symptom severity as 
determined by the ASI was an important patient parameter to 
examine. It is important to bear in mind that the 'rospital was an 
inpatient psychiatric hospital with high security locked units 
and that 81 percent of the research population had a high psycho-
logical symptom severity profile. 
"In concept and function, the ASI psychiatric severity rating 
is comparable to the health-sickness rating scale developed by 
Luborsky (1974) or its derivative, the Global Assessment Scale used 
in the SADS Interviews (Endicott et al., 1976) and provides a 
genera 1 estimate of ov era 11 psycho log ical /psyc hia tric statu s" 
(McLellan, 1981). 
Patients in the research population who were rated low in 
severity were generally asymptomatic or had problems of anxiety or 
depression in their past, but no clear history of recurring or 
persistent symptoms. Patients in the high-severity group generally 
reported severe and prolonged symptoms such as suicidal ideation, 
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- ---t-heught d l-s'order and/or cogn it ive- con-fliS-ion. In -fa bl e 33 below, 
the psychiatric symptom severity rating was subdivided into high and 
low grou ps . As can be seen in Tabl e 35, 81 percent of the research 




PSYCHIATRIC SEVERITY RATING BY DRUG USE AT FOLLOWUP 
(N=97 ) 
Low Severity High Severity 
Drugs at Foll owup 
No 47 47 
Yes ~ -ll-
100% 100% 
(N=19) (N=78 ) 
As shown in Table 33, high' and low psychiatric-symptom severity 
alone did not predict a drug-using outcome. 
Next, in Table 34, a three-variable presentation compares 
psychotropiC medication with drug-using outcomes, statistically 
controll ing for psychiatriC symptom severity. 





PSYCHOTROPIC MEDICATION ADMINISTRATION BY READDICTIVE LEVELS OF 
DRUG USE AT FOLLOWUP CONTROLLING FOR PSYCHIATRIC SYMPTOM SEVERITY 
(N=93 ) 
Psychiatric SymptOM Severity (AS!) 
Low Sever ity High Severity 
PSlchotro~ic PSlchotroQic Med icati on Med ication 
Yes No 
Using Drugs 
at Followup Yes 
83 33 No 74 
17 67 Yes 
...li 
100 % 100% 100% 






Fishers Exact. NS. X
2








In the above Cross tabulation under the low psychiatric severity 
portion-. a "Fishers exa"ct test was employed due" to a _small N. For the 
low pSYfh.iatric severity gr-ou.p --there was--no--s-ig·ni-f·i·ca·nt-d-iff-er-en-c-eon----------
outcome across the psychotropic and non-drug-using groups. However 
upon examining the relative proportions in the low severity group I 
would expect that with a larger N this result would achieve significance. 
Of the patients in the high psychiatric severity group. those who were 
medi.cated for their psychological symptans were significantly more 1 ikely 
to be drug-free at followup than those who were not medicated. This was 
an important finding because S,Ylllptoms alone did not predict drug-using 
outcomes unless medication was used. Again. this high psychiatric 
severity group may be referred to as self-medicators or crossovers 
due to their treatment response. 
Table 35 below shows that the majority (75 percent) of those 
on psychotropic medication also were high in psychiatric severity: 
TABLE 35 
PSYCHIATRIC SEVERITY BY TYPE OF PSYCHOTROPIC MEDICATION 
(N=95) 
Psychiatric Severity (ASI) 
PSlchotr02ic Medication low High 
Tricycl ics 5 16 
Neuroleptics 1 1 
MAOI 0 3 
NA lL ....§J 
TOTAL 19% 81% 
(N=18) (N=7?) 
110 
MAOI and Tricyclic medications were indicated for depression 
and, as stated previously, accounted for the majority of 
the psychotropic medications prescribed to the research 
po pu 1 at ion. 
Interestingly enough, considering the general prohibition on 
the use of psychotropic medications in drug-abuse treatment, fifty-
eight unmedicated patients were in the high psychiatric symptom class 
and medication thus might have been indicated for these patients. 
Table 36 below compares the preinduction drug of addiction, 
identified as opioids or cocaine, with the category of psychotropic 
medication: 
TABLE 36 
DRUG CLASS USE BY TYPE OF PSYCHOTROPIC MEDICATION 
( N=95) 
Opioids 
Ps~ehotroR;e Med ieat; ons 
Tr icycl ics 15 
Neuroleptics 2 
MAOI 2 









Table 36 shows that in this research population -more opioid 
addicts have been medicated than cocaine addicts. although t_~~ __ ~o~or~-__ 
---------tions--1ndicate relatively more cocaine addicts were prescribed psycho-
tropic medications than opioid addicts. This may be due to a higher inci-
dence of agitation experienced in a cocaine detoxification. As shown 
earlier in Table 7, comparing opioid and cocaine groups, cocaine addicts 
were significantly more likely to be drug-free at followup than opioid addicts. 
Summary. Recidivism to regular drug use usually occurs 
on emotional impulse within the first three months after release 
from inpatient treatment. Assuming the high psychiatric severity 
group may have been self-medicators. those patients who experienced 
s ignif icant psyc hiatr ic symptomology and became add icted 1 argely due to 
the symptom-reduction effects of nonprescription drugs. According to 
Resnick (1979), this group tended to\\8rd less favorable followup out-
comes. Self-medicators among the research population may have been at 
higher risk of impulsive readd1ction during the critical period 
of reentry into the community. The hospital's inpatient drug 
abuse treatment program has stringent control s and intensive 
professional support. 
An outpatient reentry protocol offering individual and group 
(psychosocial) supports may not have been enough for many of these 
patients. Resnick, referring to the conditioned-abstinence hypothesis. 
stated that in addition to psychosocial support, patients may need 
biochemical support to achieve successful outcomes. 
The data suggested that high psychiatric severity patients may 
have benefitted from short-term biochenical support in the form of 
psychotropic drugs during the critical reentry period when 
emotional lability was at its peak. Without biochemical 
support (in addition to a well-developed reentry protocol) there 
was a greater likelihood that a patient, in a period of 
increased emotional lability, would impulsively use illegal 
drugs, for their symptom reduction effects, and, thus become 
readdicted. The data suggest that controlling mood lability with 
appropriate psychotropic medications increased the probability 
that the patient would successfully negotiate the critical 
reentry period and remain drug-free. 
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The reentry period may have been a relearning period during 
which short-term psychotropic administration was indicated as an 
adjunct to psychosocial treatment. The findings indicated that this 
W!S especially true for those patients who were identified as "self-
medicators", i.e., those with high psychiatric symptom severity. 
The data also suggested that a community reentry period facilitated 
by psychosocial and short-term biochemical support may yield better 
followup outcomes, espeCially for those patients in the research 





this study are nonexistent because of the very recent introduction of 'lttis 
nonopioid med ication into some detox ification treatment strategies. 
At the time of the present study, February 1982 to December 1982, 
Clonidine still awaited FDA approval .* 
As a detoxification medication Clonidine significantly reduces 
the discomfort due to withdrawal from opioid addiction. Previously 
all detoxification medications were opioid-based compounds such as 
darvon N and methadone. However, when using opioids for detoxifica-
tion the patient still has to go through a six-to-ten day detoxifica-
tion period when the opioid-based detoxification medication is with-
drawn for his system to be drug free. Additionally, Clonidine does 
not produce euphoria as do other detoxification medications. This 
point is important to the following explanation: 
Commonly, the addiction level of a 'patient at entry to a drug-
treatment facility is determined via self-report of the patient's 
street drug dosage and the money spent for drugs. Obviously, this 
self-report can be misleading insofar as the variable quality and 
pr ice of street drugs is concerned. Or, if the patient has been 
previously placed on methadone until he reports feeling physically 
comfortable, then this dosage level of methadone is used as an 
*As of October 1983 Clonidine still was under study and awaiting FDA 
approval for an opioid detoxification indication. 
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indicator of addiction level. However, this method of indexing 
addiction level poses intrinsic problens. SpeCifically, when a drug 
addict enters detoxification treatment, prescribing a euphoric drug 
may encourage his accepting higher levels of it because it probably 
will be his last opioid-induced high prior to detoxification. The 
available literature previously has reported dose-dependent outcomes 
(Resnick, Washton 1978; Rawson 1979) based on either self-reporting 
of amount, price and frequency of use or a stabilizing methadone 
dose. A methadone stabilizing dose may indicate other parameters 
such as a patient's motivation and/or willingness to become drug-free. 
These motivational traits or attributes would seem to predict a less 
favorabl e outcome when the patient requests more methadone than is 
necessary for him to become stabil ized. This measurenent may reveal 
more about motivation than the biological level of addiction. 
Therefore, the stabil izing methadone dose and the self-report 
measurements both are subject to measurement probl ems. 
In regard to a Clonidine detoxification strategy, on the other 
hand, at high dosage levels Clonidine produces disphoria due to the 
patient's marked reduction in blood pressure. In a Clonidine 
detoxification procedure, high doses indicate a greater need for 
withdrawal-s.)mptom reduction rather than a need to get high. 
Additionally, the longer a patient is administered Clonidine the 
greater his addiction may be. 
The methadone stabil izing dose is generally considered a poor, 
if not misleading, measurement of the biological addiction level. 
Clonidine, however, because of its noneuphoric effect does not 
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involve the drawbacks of methadone as a measurement of drug-use 
sever-Tty at entry to treatment. Clonidine may be a usefu.l, accurate 
-_._--- --------------
____ and-u.nb·iased index for d-etermi"ning addittlon levels because it by-
passes the reporting problem and the induced-euphoria problems 
encountered with traditional opioid detoxification medications. 
In the present study, ind icators of add ict ion 1 evel s used were 
incorporated in the ASI and included years addicted, frequency of 
drug administration, weekly amount of money spent and number of 
previous treatment episodes (see Appendix B-3). Clonidine's fourth-
day stabl1 izing dose (i.e., how much Clonidine was needed /JRNI on the 
fourth day of the detoxification protocol) and the length of time a 
patient used Clonidine might have been indicative of pre-treatment 
addiction level. Therefore, both the fourth-day stab;l izing dose and 
length of Clonidine administration were used in the following as 
independent variables. Twenty-three patients in the research 
population used Clonidine as their detoxification medication. 
All of the following Pearson correlations in Table 37 were 
significant at P<.05 (N=23): 
The significant relations among the variables in Table 37 were both 
logically and statistically related to pre-treatment level of opioid use 
and there was some overlapping across the two sets of variables. 
Based on the previously stated assumptions regarding measure-
ments of the biological level of opioid drug use and the above 
correlation relationships, a multiple regression was performed using 
an ASI rating of drug-use severity on entry to treatment as the 
dependent variable. Both the Clonidine fourth-day stabilizing dose 
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TABLE 37 
SIGNIFICANT CORRELATION RELATIONSHIPS BETWEEN TIME AND. DOSE OF CLCNIDINE 
AND VARIABLES LOGICALLY RELATED TO LEVEL OF OPIOID USE 
(N=23 ) 
Variables Related Time on Cl on id i ne 
to Drug-Use Level r 
Years add icted .55 
Frequency of daily .61 
administ ation 
Weekly amount spent .38 
Monthly amount spent .41 
Number of previous .49 
treatment epi sodes 
Stabil izing dose of .51 




Year s add icted .36 
Drug severity (ASI) .53 
Drug summary post .38 
trea'bnent 
Time on Clonidine .51 
P< .05 
and the time spent on Clonidine for detoxification were used as 
independent variables as seen below in Table 38: 
-- - - - -. -------------
TABLE 38 
REGRESSION ANALYSIS OF TIME AND DOSE OF CLONIDINE USE--
PREDICTING PRE-TREATMFNT DRUG USE SEVERITY RATING (ASI) 
(N=23) 
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Pre-treatment Drug-Use Severity Rating (ASI) 
Ind e~end ent 
Var iabl es 
Clonidine Stabilizing 
dose 
Time on Clonidine 
1 x 2 Interaction 






R R2 Beta 
.54 .29 1.13* 
.56 .32 0.30* 
.61 .38 -.89* 
This regression in Table 38 demonstrates that both variables--
Clonidine stabilizing dosage and time on Clonidine--significantly contributed 
to the explanation of the variance of the dependent variable drug-use 
severity on entry to treatment. Additionally. the interaction term in 
Table 38 indicates there was a definite, robust interaction between 
time on Clonidine and fourth-day stabilizing dose, resulting in the 
combination of time and dosage offering the best explanation of the 
Pre-treatment drug-us~ severity variance. To explain this amount of 
variance with a small N of 23 is a significant, important and 
robust finding. Regarding dose-related outcomes, the interaction 
of time and Clonidine dose as a detoxification procedure far 
outweighed methadone as a useful. valid and unbiased indicator of 
drug-use level on entry to treatment. 
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The next step was to determine whether this measurement of 
opioid addiction significantly related to dose-related drug-treatment 
followup outcome. Using dichotomous variables comparing patients on 
Clonidine to those who did not elect to use Clonidine as their detoxi-
fication medication, significant differences appeared neither on drug-
using outcomes nor on process outcomes such as completing the 
inpatient program and/or entering the outpatient program. 
However, when looking at drug-use at foll owup as a ssessed by the 
AS! (used in most regression analyses in this study). a probl en 
occurred. Specifically, the number of subjects on Clonidine was 
twenty-three which might have been adequate for two independent 
variables since the Clonidine dose and time were strong continuous, 
concrete variables. However, when looking at drug-use outcomes at 
followup, it must be remembered that a full followup interview was 
obtained for 64 of the 101 subjects in this study. Consequently, 
due to missing data, the number of subjects for the regression 
dropped from 23 to 14 which did not adequa tel y meet the requ iranents 
for the regression analysis. An N of 14 would make it very difficult 
to reach statistical significance. With this problem in mind, we 
proceed to Tabl e 39. 
TABLE 39 
TIME AND DOSE OF ClONIDINE PREDICTING POST-TREATMENT 
DRUG USE SEV1~~1X )RATING (ASI l 
Post-Drug Severity Rating ASI 
Indeeendent 
R2 Varla 61 es r R Beta 
-
Stabilizing Dose -.19 .19 .04 .76 
on Clonidine 
Time on Clonidine .25 .44 .19 1. 46 
1 x 2 Interaction -.06 .57 .33 -1.93* 
*Sig. (p< .05) 
The interaction term in Table 39 significantly increased the 
amount of outcome variance accounted for and expla ined a great deal 
. . 
of the drug-use severity outcome variance. Although especially 
surprising when operating with such a small N where the probabil ity 
of a significant increase in explained variance is low, therefore, 
viewing this as a preliminary analysis the length of time a patient 
remained on Clonidine times the fourth-day stabilizing dose 
predicted poorer drug use outcome at foll owup. With a larger N 
this finding probably would be significant and important for the 
explanation of the outcome variance. 
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These results plus a significant (P<.05) Pearson correlation 




- ------sulTltl·ary-post-;.treatment -(wh.ere the-dr",g---summary is the sum of how 
many drugs u sed and how many days a patient u sed drugs in the month 





The goal of the present study was to evaluate the drug-abuse 
treatment program at a private psychiatric hospital located in the 
north eastern United States. During the period covered by 
this study, February 1982 to December 1982, it was found 
that the patient population undergoing treatment for drug 
abuse was atypical of those patient populations discussed 
in the ava ila bl e 1 iterature (see Chapter 2). 
More specifically, the 101 patients originally included in 
the research pOJX.Ilation for this study tend·.ed to be white male 
professionals in their late twenties who earned almost $45,000 per 
year. In addition, one might suspect a correlation existed between 
the patients' relatively high socioeconomic status and the cost of 
treatment--$6.000 per week for a semiprivate room at the time of 
this study. 
Besides the patient population and the cost, a number of 
other unusual factors were detected during the study period 
concerning the drug-abuse treatment program. First, this 
is one of the few hospital based inpatient programs for 
the treatment of drug abuse; al though there are many programs for 
drug abusers. the overwhelming majority are outpatient programs. 
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Second, within a carefully designed treatme.nt framework. t.be. 
patient was viewed as an individual whose personal history and: 
.-- _ .. _--
--------- ---
-- - - _.-
... ----. -- -···pro·M-enfs-sfiould be, and were, th.e focus of intense scrutiny and 
followup attention. 
Third, and perhaps of greatest significance, the 
program was staff-intensive, possessing abundant personnel and 
physical resources. For exampl e, the treatment staff includ:ed 
socia 1 1f«lrkers, ex-addict drug counselors, psychologists, psychia-
trists, psychiatric nurses, and medical internists. Also, the 
hospital had its own laboratory where analyses were carried out of 
the patients· biochemical status and an ongoing research program 
'IllS conducted. Modern, state-of-the-art medical equipnent was 
employed and el egant furn iture and modernistic pa intings enhanced 
the appearance of the five hospital buildings including access to 
a well-equ i pped gymna s ium. 
The elaborate facilities and well-qualified treatment 
team were found to support, as noted in Chapter 1, a three-
stage treatment strategy: 
a. inpatient evaluation, d.etoxification and 
stabilization (two weeks); 
b. inpatient drug-free therapy and. rehabil itation 
(six weeks); 
c. outpatient reentry into the community. 
The eight-week inpatient stage was found to be composed 
of continuous evaluation, reevaluation and therapy through 
different forms of group and individual meetings between patients, 
patients and their family members and./or close friends, and. 
patients and. treatment-staff members. 
In regard to the 1 iterature on the subject of drug-abuse 
treatment, the discussion in Chapter 2 showed that evaluation and 
treatment of drug addiction remains controversial. Methadone has 
achieved limited acceptance as a treatment agent, perhaps because 
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of its rela tivel y long involvement with d.rug-addict ion treatment. 
More recent drug canpounds such as Nal trexone, Cl onid ine and certa in 
psychotropic drugs are still in the experimental stage, however 
prom ising they may have a ppeared to be in certa in treatment env i.ron-
ments. 
One might tentatively conclude, with regard to the literature 
that many valuable. even pioneering. studies have been cond'ucted 
with selected patient populations. A further step in building on 
previous studies might well be the widespread acceptance of generally 
agreed-upon evaluation criteria and standards. 
In conducting the present study. as seen in Chapter 3, 
"Methodology," a three-part study design drew upon the following 
data base: 
a. pre-.and post-treatment patient interviews 
incorporating the AS!, Drug History variables 
and a natural support system matrix; 
b. patient files and pharmacy records; 
c. the Brief Psychiatric Inventory; 
d. the Beck Depression Scale. 
In order to gain patient acceptance and observe hospital 
routine the researcher was allowed to accompany treatment 
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staff msnbers during their meetings wi.th patients and at 
. . 
exclusively staff meetings. The inside view of the treatment 
-----
_---pr..og·ram-'-s--·oper·ati·ons was invaluable -in-obtaini.ng patient 
cooperation. 
D.itcome 
As seen in Chapter 4, "The Researcfl Data" of the 101 patients 
in this research population~ 51 were readdicted at follo\\Up 
(20 of whom reentered treatment prior to the follo\\Up interview). 
Forty-six were drug-free and data for 4 on this parameter was 
unobtainable. Seventy-four patients successfu.l1y completed. 
the inpatient treatment protocol, 25 d:id not and 2 died. Of 
the 74 patients who completed the inpatient program 51 entered 
the outpatient program. 
The results indicated tbat the longer a patient remained 
in treatment the more likely he was to be drug-free at followup, 
espe.cially if the patient entered tbe ou.tpatient program. These 
results suggested that outpatient involvement was a major 
component in the treatment success of the.se patients. These 
-.. 
conclusions supported length of stay 1n treatment as one of 
the most substantial indicators of outcome ·in the 11.terature. 
In other words, the longer a patient stays in treatment the 
greater the likelihood that he will be d:rug-free at follo\\U.p. 
Clinically, the implication is that a significant effort should 
be made by treatment personnel to encourage outpatient partici-
pation. 
Antecedent factors that predicted length of stay in 
treatment were economic support status and the existence of 
a supportive conjugal dyad. The better the economic support of 
the patient at treatment entry, the longer his length of stay 
in treatment was likely to be. A supportive conjugal dyad also 
indicated a longer stay in treatment. Consequently, the presence 
of both var ia bl es yielded better treatment outcomes. 
Antecedent factors that directly indicated outcome were 
1 ega 1 involvement and type of preindJction drug of abu se. Greater 
1 egal involvement directly indicated. poorer fo 11 owup outcanes. 
Of the variety of preinduction drugs of abuse methadone 
patients made up the largest proportion of treatment failures. 
When comparing heroin and methadone vis-a-vis outcome, those 
addicted to methadone were significantly more likely to be 
readdicted at followup than were heroin addicts. This fact 
should cause concern for proponents of methadone treatment, 
particu.larly professionals responsible for recruiting 
addicts--especial1y the young--into methadone maintenance 
treatment. Speedballing refers to a potent mixture of heroin 
and cocaine. Although not posing the treatment problems 
125 
- .. - '" .. -
presented by methadone addiction, speedballing accounted for the 
--s'ec'ond-largest-gr-oup of-treatment -failures. 
When compar ing coca ine addicts to opioid add icts, the opioid 
addicts were significantly more likely to be readd,icted at fol1owup 
than were the cocaine addicts. It is interesting to note that age, 
sex, income and other drug-history variabl es did: not pl ay a rol e 1'n 
these relationships. 
The exi stence of positive treatment process var hbl es such as 
1 ength of stay in the inpatient program, su,ccessful completion of 
the inpatient program, entry into the outpatient program and length 
of stay in the outpatient program all contributed' to more positive 
followup outcomes. Entry into o!Jtpatient and' length of stay in the 
outpatient program accounted for the majority of the post-drug-use 
severity outcome variance explained in the hierarchical regression 
analysis (see page 71). These results indicated, that ,the 
longer a patient stayed in treatment the more successful he was 
likely to be at followup. 
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The sixty-four patients who were personally contacted for a 
followup interview were significantly more likely to be drug-free at 
followup than those who were not contacted d'irectly. This result was 
consistent with other findings in the literature, and may have 
related to, for example, stabil ity in 1 iving arrangements or desire 
on the part of the patient to be contacted at followup. Hopefully, 
future studies can further explore the significance of followup 
interviews beyond the limitations of the present study. 
.~ . 
The Residualized Change 
Score Analysi s 
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Res idua lized change scores, were. c:omputed accross the pre- and 
post-administra tions of the ASI in seven 'l1fe areas: med tca 1 
severity. economic support status severity. alcohol severity. drug 
sever ity. 1 ega 1 severity. and. family soc i.a 1 severity. Tbe purpose of 
this analysis was to determine in.which life areas patients in 
the research population changed duri,ng the treatment and post-treatment 
periods. 
The resul ts show that med ieal severity did not change significant-
ly. this is not unusual since l~ngstanding med:tcal problems are not 
usually amenable to cbange during a six-month period. 
Economic support status severity. bowever. did change significant-
ly as did alcohol severity. legal severity and family social severity--
all of these variabl es being logically related' to a drug-using life-
style. However. neither d'rug sever ity nor psyc hiatric severity changed 
significantly. These outcomes suggest that perhaps diffused treatment 
goals might, indeed, have impacted on the patients' lives. but not. 
unfortunately. on their drug-abusing patterns or medical and psychia-
tric problems. These various changes were not ~terrelated with another 
measures; therefore. any assumption that drug' use in and of itself causes 
problems in other life areas is oversimpl ified in terms of the 
findings (Lukoff, personal communication 1983). 
Socialization Variables 
The data from the present study support the critical periods 
theory of Kleinman and Lukoff (1980). This analysis indicated that 
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employment status, criminal involvement and support thr~ugh a conjugal 
reI ationship a ffected treatment outcome either ci irectly or in 
____________ combination---w·i-t-h trea tment ·-process -v·ar-i·a-bl-es-. ------------- --
The second critical period in the lives of drug addicts 
accord ing to the a bove researchers encompasses age of first 
drug-a buse treatment contact and: .age of first arrest. The 
data in the present study support the truncated social ization 
hypothesis (Lukoff, 1974). Here, the earlier any of the above deviant 
behavior patterns occurs the more profound became the related behavioral 
probl ems. 
For exampl e, earlier identified drug abuse or 1 egal prohl ems 
occurring in the patient's life significantly related to low 
economic support status and poor conjugal relations. The earlier 
the first drug abuse contact occurred· in the life of a patient, 
vis-a-vis a professional treatment agency. the more profound the 
(identified) drug-abuse history tended to b~. With the occurrence of 
more prior drug abuse treatment episodes, -it was more likely that the 
patient would he readdicted and/or have higher levels of post-d-rug-use 
severity at followup. 
Implications for Social Work Treatment 
The ecological perspective in social work provides a conceptual 
framework for program and practice impl kations related to the present 
study. Accord i ng to Germa in (197 9). an ecological practice orientation 
ideally is one directed toward improving the transactions between 
people and environments in order to facilitate a~aptive capacities 
and improve the environments for all who function within them. 
These findings herein suggest environmental and social inter-
actions have direct effects on treatment compliance and outcome 
success. 
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These find ings support the va tue of adol escent-d.irected drug-
intervention programs stressing the need for adaptive social trans-
actions between the adolescent and his family. friends and the 
education and criminal justice systems. These early intervention 
programs should be community-based and focused on the young patients 
and their family. social and community problems. 
Conjugal associations and friendship networks (whether drug-
using or not) relate to treatment outcome, supporting a social work 
treatment effort specifically emphasizi.ng either positive conjugal 
support or separation from a spouse or friends who may create a 
negative treatment environment. 
Psyc ho 109 ica 1 and B ioc hem ica 1 
Treatment Strategies 
Recividism to addictive drug use levels following treatment 
usually occurs on impulse within the first three months· post-
detoxification and inpatient treatment. 
Those patients who experience significant psychiatric 
symptomology (that is, self-medicators) may be more prone to 
readdiction largely due to the symptom-reduction effects of illegal 
nonprescription drugs. According to Resnick (1979), self-medicators 
are those patients who initially become addicted due to alleviation of 
their own psychiatric symptoms, drop out early from treatment and 
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generally have less favorable followup outcom~s. 
McLellan (1980) also supports tb.is contention in his r.esearch.:. 
---- --- -----
.. ___ s.pec:ff--ical-l-y-.-t-hose patients who--ent-er -treatiilent with -h-tgh psychiatric 
S,Yl11ptom severity (according to th.e AS!) are the grol,lp 1 ess li.kely 
to have successful fo11 owup outcomes. Thus. sel f-rned ica tors may be 
at higher risk of impulsive readdict10n during the critical period of 
community reentry. 
The Treatment Program 
The inpatient program for drug abuse treatment had' strong con-
trols and intensive staff and patient support. The point here is 
that an outpatient community reentry protocol offering individual 
and group therapeutic support may be inadequate for many patients. 
Resnick (1979), in referring to the conditioned abstinence response 
hypothesis, suggested that. in addition to psychosocial support, 
drug a buse patients may need biochemical support for successful 
treatment outcomes. 
The data resulting from the present study suggest that, in 
addition to psychosocial support, high psychiatric severity patients 
espec ia 11 y, may benefit fran short-term biochem1ca 1 (psychotropic 
medications, primarily antidepressants) support, when indicated, 
during the critical community reentry period when emotional lability 
is at its peak. Without biochemical support (in addition to a well-
developed psychosocial reentry treatment strategy), a greater likeli-
hood exists that the psycbiatrically severe patient, in a period of 
increased emotional labil ity, will impulsively use illegal drugs for 
their s.)llllptom-reduction effects and thus become readdict~d. 
A drug-free commu.nity reentry period. in effect. may be a 
necessary rel earning period during which short-term psychotropic 
administration, when indicated. could function as a usefu.l adjunct 
to a psychosoc ia 1 outpati ent cormnuni.ty reentry treatment strategy. 
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These findings in this study indicated that this was especially 
true for those patients identified: as self-medicators. These results 
und.er scored the great need in d.rug abuse treatment for a wel1-
developed psychosocial and biochemical outpatient treatment strategy 
aimed at community reentry. 
One of the areas for future research might be a randomized 
clinical trial comparing multiple treatment groups--i.e., drug, no 
drug, and high- and low-pathology groups--to d·etermine the util ity 
and efficacy of the treatment d.escri bed in the present study. Such 
researc h idea lly should employ strict control s on drug type, dosage. 
body wei.ght and duration of drug administration. To achieving the 
goal of a more comprehensive assessment of the existence and nature 
of pathology, the DSM III could be used in combination with the ASI. 
Clonidine Detoxification 
. 
The biological level of street addiction, or dose-related 
analysis, has suffered in the drug abuse literature from a lack of 
an accurate and relfabl e measurement standard. 
I~ the present study. Clonidine dose times time interaction 
(compared to present assessment methods) appears to have served as 
an unbiased biochemical indicator of addiction level. The data 
suggest that this Clonidine index is capable of indicating dose-related 
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outcomes. Spec ifically, ~igher 1 evels of opi.oid addic~ion .at intake 
were inversely related. to success rates. in treatment. These a.nalyse.s 
-are-, of-c·ours-e~ ·prel-imi.nar,Vind require further testi.ng. am~ng varyi.ng 
populations and program environments where controls relating to dose, 
time and. weight can be closely monitored. 
Summary 
All things considered, the dru.g-abuse treatment program 
was a via bl e, treatment al ternative for drug-abuse probl ens. 
Generally, social and treatment process variables conformed 
to the existing drug-abuse literature. However, certain psychological 
variables did not conform. but this might have been due to the 
administration of psychotropic med:fcations to patients with obvious 
ps,YChological probl ems--thus changing the direction of expected 
results. Generally, in this study. there were no significant age or 
sex differences regarding outcome among this research population. 
The drug-a buse patient who was most 1 ikely to be successful a.t 
outcome had a strong economic support sta tus. a supportive conjugal 
mate, less criminal involvement. entered the outpatient program, and 
most 1 ikely took psychotropic med ications on discharge to outpatient 
status. 
This patient profile is directly related to a longer time in 
treabnent and successful. treatment outcane. 
One might remember at this juncture that, in general, there 
have been two major treatment approaches to the drug abuse patient: 
a) methadone. which stresses only biochemical processes and operates 
133 
under the implicit assumption that psyc.hosoci.al causati.on is u.nfmportant 
to treatment outcome, and b) dr.ug-free outpati.ent a.nd. therapeuti.c 
community approaches which have stre.ssed. psychcsoc.ial processes that 
essentially bypass biochemical interventions. 
The data in this stud.y would seem to und·e.rscore the. importance 
of an interactive view in dru.g-abuse treatment, that 1s, one that 
offers a combination of social. psychological and biochemical tr.eatment 
modal i.ties yielding an interactive trea.tment strategy capabl e of 
meeti.ng or ful fHling the treatment needs of drug-a buse pat ients. 
One hopes, then. that the present study has contri buted' to a more 
complete understanding of the prob.lems associated with the treatment 
of drug-abuse patients. 
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An Improved Diagnostic Evaluation Instrument for Substance Abuse 
Patients 
The Addiction Severity Index 
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The Addiction Severity lDdelit (AS!) is a structured cliDieal interview developed to fill the 
aeecI for a reliable, valid. and standardized diqnoatic and evaluative instrument in the field 
of alcohol and druc abuse. The ASI may be administered by a technician in 20 to 30 minutes 
producing 100point problem severity ratinp in each of. areas commonly affected by 
addiction. Analyses of these problem severity ratinp on 524 male veteran alcoholics and 
drug addicts showed them to be hiahly reliable and valid. Correlational analyses using the 
severity ratings indicated considerable independence between the problem areas, suuestins 
that the treatment problema of patients are not neceesarily related to the severity of their 
chemical abuse. Cluster analyses using theee ratinp revealed the presence of m aubp'oups 
having distinctly different patterns of treatment problema. The authors suggest the use of 
the ASI to match patients with treatment. and to promote Ift8ter comparability of research 
findings. 
The mental health field has traditionally profited 
from attempts to divide patients into homogeneous 
groups based upon relevant symptomatology. As in 
the examples of psychosis and especially affective 
disorders, such diagnostic classifications have added 
focus to research efforts and improved the specificity 
and effectiveness of treatments. However, within the 
field of substance abuse treatment, efforts to evaluate 
and classify the patient population have been far leu 
useful. In our view, these less than satisfactory at-
tempts are due in part to a somewhat restricted view 
of addiction, and in part to failure in developm, a 
standardized, reliable, and valid evaluation instrument 
which would be suitable for use with both alcoholic 
and drug-addicted patients. The design for such an 
instrument was first proposed in a National Institute 
of Drug Abuse Conference on Treatment Efficacy (14, 
30) and has led to the development of a multidimen-
sional clinical research instrument for addicted clients, 
the Addicton Severity Index (ASI) (13, 26, 27). The 
present paper reviews some of the existing problems 
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with diagnostic evaluation in the field of substance 
abuse and reports the results of reliability, validity, 
and patient classification studies using the ASI. 
If addiction is considered as a unitary treatment 
problem manifested by a psychophysiological depend-
ence upon a particular chemical agent, then the prob-
lem is adequately described by the symptoms of 
amount, duration, and frequency of chemical use. Em-
phasia upon these symptoms has led to the traditional 
diagnostic classifications of alcoholic VB. drug addict. 
However, within recent years there has been increas-
inc recognition that the dichotomous typology is ov-
ersimplified (8, 14), is not systematically related to 
treatment outcome (1, 31), and does not correspond 
well with actual patterns of abuse (2,3,24). 
Despite ,eneral recognition of the variation and 
camplenty of treatment problems within the sub-
stance abuse population (12,33,37), it has been diffi-
cult and time consuming to develop individual analy-
ses of each patient's problems. Although a number of 
particularly useful instruments have been developed 
to assess the nature and utent of actual chemical use 
(29, 34), very few provide a comprehensive analysis of 
addiction-related treatment problems (32, 35, 38), and 
virtually none have been developed for use as a diag-
nostic clinical instrument (32). 
An eumination of more than 70 admission surveys, 
questionnaires, and indexes currently in use suggested 
several major problems from our perspective. Posaibily 
the most serious of these is the restrictive concentra-
tion on pattem-of-chemical-use information (i.B., refs. 
10, 18,36). Whereas most of these instruments provide 
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excellent objective information conceminl amount, those treatment problems which may have contrib-
duration, and pattern of chemical use. they pnerally uted to and/or resulted from the chemical abUlle. The 
do so at the cost of" ezc:ludiq or ieriously limiq obj8cdve of the Asf is to prOduce -a problem l18Yerity 
information on associated treatment problema. For profile of each patient tbroup an analysis of siz 
examp'l~. _-' Jarp _number _of these inatrumenta lack pneral .,. .. -which- commonly-result intreatmeDt 
items which illusuate the patient's pretreatment liviq problema. Th ... include: a) chemical abuse; b) medi-
conditions. family suPPOrts. and work and educational cal; c) psyeholOJical; d) lepl; e) family/aocial; f) em-
--skills;-T-bese-are-the social-88I8t8and--liabUiti.f(23) -- -plOyment7support. --------- - -----
which may in Jarp part predict his paet-tnatment WithiD the ASI, severity is de~ .. "need for 
status (22). additional treaanent," and oft'ers a potentially differ-
An additional problem which affects the coatent of ent estimate of severity thaa other perspectives. For 
even the more comprehensive iaatrumenCI is the influ- .sample. the patient who has very poor uncorrected 
ene of a particular approach. orientation. or stratei)' vision. but baa been fitted with Pasaes which allow 
throughout all itelDS. For eumple. an admisaion in- him to ... adequately. would still be considered to 
terview which examineS the patient'. history of addic- have a severe vision problem if severity were defined 
tion from a psychological perspeetive (15, 17) may be .. "deviation from optimal functicm." However. the 
heavily loaded. with psycholoP:ally oriented queetioaa ASI estimate would be quite low since no additiolltll 
and concentrate only upon those aapecta of the addic- tnatlneDt would be requind. This operational defiDi-
tion which are amenable to a psyeholoaica1 interpre- don of severity was adopted siDee it relates directly to 
tation. This often resulta in a biased picture of the the primary mission of health case facilities: delivery 
patient'S syndrome by omisaion of relevant informa- of treatment. 
tion which may fall outside the particularorientadoll The severity of each of the treatment problem areas 
of the instrument. In its extreme form this is !DOlt is _eued individually and independendy throulh 
clearly shown by the absence of dnaI abuse questiona two types of informatioa. 
in alcohol-oriented. questionnaires, or the cunory 
treatment of alcohol abuse in drul-oriented scalee. 
Several problems are also noticeable in the orpni-
zation and adminisuatioD of many substance abuae 
instruments. Many of the more comprehensive inter-
views are not sufficiently intep'ated. to pennit a sum-
marized account of specific treatment problema. Oth-
ers make no attempt to separate objective items &om 
subjective patient reports. Finany, these instnunenta 
are often quite lengthy and may require administra-
tion by a professional or hiPly trained interviewer. 
In summary. our evaluation of the majority of sub-
stance abuse interviews currently in use sug_ted 
that many lacked. the orpnization which would permit 
the computer codinl necessary for the researcher, 
whereas others lacked the orientation and/or the in-
formation necessary for a rapid and accurate clinieal 
evaluation. These problems, plus our need for a brief, 
easily __ ad_min"red formato_and tbeneed wichiD the 
field for an analytic approach to the addiction syn-
drome. sugested. the desipt for an alternative evalu-
ative instrument. 
Deacripdon of the AddledoD SeYerit71Dder 
Desi{pa 
The desip of the ASI is based upon the premiae 
that addiction must be considered in the contut of 
, The ASI and the manual for ilB UIII ant available I'ram the ..... 
author. 
06jectiw l11/ormatiota 
The data collected withiD the objective section de-
tail the number, intensity, and duration of problem 
symptoms in each of the six areu. Verifiable data 
from objective questions as well as test results, lab0-
ratory reports (where appropriate), physical uami-
nations, and psycholoPcal interviews are collected to 
develop a factual representation of the patient's life 
pattem in each of the sis areas. 
Patie1lt'. Judpa.",. of Sewrity 
The second of each problem area is desiped to 
measure the subjective intensity of problem symptoms 
and allows him to participate directly in the evaluation 
of his treatment needs. The patient is requested to 
rate. usinc a 5-point scale. the estent to which he baa 
beenbothered-by-problems in- each of the sis -areas. 
and the e:tent to which he feels that treatment for 
tboee problems is important, as followa: 
O-notatall 
l-sliPdy 
2 - moderately 
3 - considerably 
" - extremely. 
The time frame for th .. eva1uatioaa ill the previous 
30 daYit pennittiDI a recent... meat of perceived 
problem aewrity as well as a time-bued ratinl which 
may be compared with subsequent ratinp foDowinl 
treatment. 
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Severity RatiDp 
The data from the objective information and patient 
report section of each problem area are intelJ'8ted by 
the interviewer to produce the severity ratinp. These 
six severity ratiDp form the basis for the clinical 
profile of each patient, providina a diqnoatic and 
evaluative 8UIDDUlI'Y of the patient's treatment needs. 
In this respect the ASI has utilized the approach taken 
by the Health-Sickness Raan, Scale (HSRS; refs. 19-
21). Both instruments rely on objective information 
and analyses of problem components as a means to-
ward developing clinical ratinp of severity. Whereas 
the HSRS uses a 100-point scale anchored by descrip-
tions based upon seven criteria of mental health, the 
ASI uses a 10-point [0 to 9] unanchored scale to 
achieve severity estimates. 
Administration 
The ASI may be administered to aU types of sub-
stance abuse clients by an easily trained technician in 
an average time of 25 to 30 minutes. The interview 
was designed for initial use shortly after admission to 
treatment, and then for repeated administrations at 
subsequent foUow-up periods. The ASI is administered 
most effectively under conditions of privacy and con-
fidentiality where the interviewer maintains an at-
mosphere of professional concem and warmth. A brief 
introduction to the interview, in which the tecbnician 
explains the desip of the ASI and the use of the 
patient rating scale, is considered necessary to the 
development of a productive and valid interview. 
The results of 750 admission interviews from 421 
alcoholics and 329 drug addicts indicate that the ASI 
is applicable to, and often appreciated by, the majority 
of patients. Many have reflected positively upon the 
patient estimate sections, commenting that they have 
been able to focus upon the individual aspects of their 
adcijctiQD. Only 11 of these 750 interviews were dis-
carded for invalid infOJ'lD8tion, and only 14 others were 
eliminated due to inadequate comprehension by the 
patients. 
Validity 
We have performed preliminary assessments of va-
lidity for each of the problem severity scales by cor-
relating the scale scores with other independent items 
having clear relationships to the particular problem 
area. These correlation coefficients are presented in 
Table 1. As can be seen, each of the severity scales 
correlates with the comparison items at midrange or 
higher levels, and in the expected direction, with the 
comparison items. Although these early results are 
encouracinl, it should be clear that these data are only 
indicative of presumptive or face validity. A more 
comprehensive ..... ment of validity requires the 
scales to be compared with several types of items. The 
scales are then expected to show high positive corre-
lation with items measuring the same trait, low cor-
relations with neutral or orthogonal items, and high 
negative correlations with items measuring antitheti-
cal or mutually exclusive traits. This measure of con-
verpnt validity (5, 6, 7) is the most conservative index 
and is a stratelY which we are currently pursuing. 
TABLE 1 
Validity of ASI Scaln: SH Mat. Veteran s"NlfJllCe AbaN cu.,.,. 








Times overdoeec:l. blackout, .. izure 
Total yean of repJar use of alcoholldnap 
AmoUDt spent on alcohol/cirup per week 
Number of cummt medical.ymptoms, VA system review 
Amount of medical disability lpellllion 
Number of previous hOllpitalizations 
Ratio of earned to UDearned iacome, put month 
Months of continuous full-time work 
Hollinphesd SES ratine 
Proponion of friends with abuae problelDl 
Proponion of family with abuae problems 
Number of clGle frienda 
Total convictions 
Total months incarcerated 
Proportion of income pined lep1ly 
MaudBIey N Scale 
Bec:k DepreBBion Inventory 
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ReUabiUty TestiD. 
The reliability of die Addiction Severity Indes was 
initially 'asseaaed durins the perfonn8Dce of our ewI-
~~Ol~ study (25taneLwas reassessed periodically dur-
inI.that scudy and in two others (28, ..0). In the baIic 
desip ODe researeh technician has eonductecl an in-
,- terview-whiJe-thNe-others-rated"the-Videocipeei" pre-
I8Dtation. The reaulta to be reported -.... bIIIed Upoll 
the judpn8Dta of these four bac:c:a1aureate level re-
search and rebabiIitadOD teclmiciaDa with little pre-
vious interviewiDg ezperiellC8. The data for 25 aWe 
veteran patients rated by these judps .... pre88Ilteci 
in Table 2. 
The first line of Table 2 shows the mea per judp 
reliability coefficients (Spearman-Brown formula; see 
ref. 39) calculated for the first 16 patienCe interviewed. 
AI, can be seen. the coeflicients an pudc:ululy hiP 
given that the judpl had had very little aperieDce 
with substance abuse patients or the ASL AlthouP it 
seems likely that the foreed uniformity of the pr0ce-
dure (one interview instead of foud may have artifi-
cially enhanced the reliability, we were maialy COIl-
cemed that the hiP coeflicieats were the result of a 
systematic bias developed over the eo ..... of tr'aiaiai 
in the inexperienced judps. To test for this poaibility, 
we repeated the reliability ass II rnent procedure fol· 
lowing a 2-month. and then a 4-month period of in-
dependent on-the-job inteJ'ViewinB experience by the 
four judies. The results for these additional reliability 
tests are presented in the second and third linea of 
Table 2, and, as C8Il be seen. no sipUfic:ant decrements 
were observed in the averap reliabiliti.. for each 
scale. 
Given the generally hiP level of reliability demon-
strated. we attempted to determine whether there 
were sicnificant differences in reliability between sev-
eral obvious subpups of our substance abuae client&. 
The second section of Table 2 presenCe reliability 
coefticienCe for theae 25 patients divided into alc:oho1ic 
(N - 14) and drua addict (N - 11) subll'OUPL Again 
the reliability results for each pvup .... quite mp._ 
'These subjeCt8weii-tli8n'diVidecfOia the basis of ap 
and by their total (sUai. of siz seal.) ieverity scores. 
to detennUuLthe.Rtent.of-dift'ereIlce-in.reliability-of-----' 
~ti eltimates. The, reaulta of these eomparisolll 
an presented iD the third and fourth (respectively) 
aectioDl of Table 2, and apin the coefficients remaiD 
hiP. with DO sipificaat diBena.ces becweea the 
JI'OUPI on any of the IC8les. 
8Mia for Scale ReUablllty 
Given the e~ raalta from our reliability 
studies. it became important to determiDe the basis 
for theae firutinp. For eumple. it WIll possible that 
hiP reliability for a ICale was produeed tbrouch a 
restricted nmp of scona, by the judps. That is. the 
full range of the severity scale (10 iDtervaJs) may not 
have been pneraUy useful to the judps, and they may 
have concentrated their estimatee around mid-level 
scores. thereby reduaa, the fuDctional ranp and ia-
creasinI the probability of iDterju. apeemeat. To 
test this poaibility we .pmjned the frequency distri-
bution of scores on each aca1e for each of the four 
judps, for a total of 325 male veter'8D alcohol and 
druf abuse pad8Da (approzimately 80 clients per 
judp). The data indicated that each jud .. bad used 
each value of each 1Cale, escept the subataace abuse 
scale, and with that ezception SCONS on all scales were 
nonna1ly diltributed IlCJ'OSI patients for each judp. 
Since the adm-on complaint of all patients in the 
study WIll subataac:e abuse, we ezpected to find a 
somewhat reduced functional range in that scale. As 
expected. the cUstribution of values was skewed toward 
higher severity estimates for all judges (mean - 6.5; 
SD 1. 7), ~ the ranp in values was from 3 to 9. 
TABLE 2 
1,.,.,.·R",., R~ C~ 011 ProIMIR s.v.;,y R~ 
(Sept.) SubjftlB 1-16 
.Nov .• Subjec:ta 17-19 
'Jan .• Subjecta 20-26 
AU subjecta l-ZS 
Alcoholics IN - 141 
0.,. patienCII (,V .. III 
Ap<35.N-lU 
Ate >35 (N'" 141 
Cum .... tive ....nty !ICON >30 (N 
... 151 
Cumulative severity score <30 (N 
-101 
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These data suggested that the high reliabilities were 
not due to a restricted range of the severity estimates, 
since each judge's scores were nonnally distributed on 
five of the six scales. However, it was still possible that 
the severity estimates were being influenced to a large 
extent by one or two items within each problem area, 
and that the high interjudge qreement was due more 
to the influence of these few powerful items than to 
the method of problem analysis. To test this possibility 
we perfonned a stepwise multiple regression analysis 
(9, 11) ~ing the items from each problem area to 
account for (predict) variation in the problem severity 
rating. The stepwise procedure incorporates that item 
which accounts for the muimum amount of variation 
first. and then adds additional items to the regresion 
equation in a hierarchical manner to produce that 
order and number of items which muimally accounts 
for variation in the dependent variable. The results of 
these analyses are presened in Table 3, which includes 
(in order) the top three or four items for each acale, 
and the proportion of variance is explained (If). As 
can be seen, this item analysis indicates that the eztent 
to which a scale rating may be accounted for (pre-
dicted) by the scale items varies according to the acale. 
For the medical and psychological acales, the amount 
of variance accounted for is rather high (.71 and .83, 
respectively), whereas the rernainina four acales show 
relatively low levels of predictiveness even &om the 
best combination of the most robust items. This sug-
gests that a certain amount of clinical judgment is 
required for these estimates in all problem areas, but 
especially in the substance abuse, legal, employment/ 
support, and family/social scales. 
In an additional analysis we asked the four judges 
to indicate those items which they felt were most 
important for developing their estimates of severity in 
each problem area. We then compared the items se-
lected by the judges with the items selected from the 
stepwise regression analysis. Results of these compar-
isons were remarkably alike between the judges (II ... 
.71), and similar to the item analysis results (r'" .80), 
indicating that the method of ratinB severity is quite 
uniform for all juqes, and that the items the judges 
say they are using are the ones actually used. 
With regard to these results, it seems clear that the 
high reliability shown in the severity estimates is not 
due merely to the powerful effect of a few items, even 
in thoee scales which do show a high cumulative Jl2. 
This suggests the importance of the interviewing proc-
ess for detel'lDininl problem severity and therefore 
makes the high reliability results even more surprising 
considering the prior bacqrounds of the judges. In an 
attempt to eumine the role of the interview process 
in determining problem severities, we ... eased scale 
reliabilities in interviews which were replayed on au-
diocassette but not 11ft", as well as in situations where 
only the completed items were given to the judges 
without any interview at all. The per judge estimates 
of reliability for the same four judges fell to .71 in the 
nonviewing interview condition, and to .58 in the no 
TABLE 3 







How important to you ia treatment ror aubetance .buIIe? 
Total yean reaular !lie of drup IlDd alcohol? 
Total days !lie of dnap and alcohol put month? 
Total times treated for aubetance .buM? 
How important to you ia medical &? 
Do you have physical problems that iaterfere? 
How many days in put month have you been bothered? 
How important to you ia employment c:ounaeq? 
How many days paid for workinI put month? 
Usual employment pattern put 3 yean? 
How many months inc:areerated? 
Are you awaitinl trial or eentence? 
Total c:hups in life? 
How important ia counaeIinI? 
How many days in put month wen you troubled? 
How many cloee friends? 
Total yean in preMftt livina litualion? 
How many days in put month _re you troubled? 
Total number or .. yc:hiatric symptoms in Iif.? 
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interview condition. These data again demonstrate the 
necessity for a strUctured clinical interview in makinf 
the severity estimates. 
One additional comment is necessary recardint the 
nature of the items found to be moat powerful ill 
accoUllting for the severity ratinp. For each of the 
scales, at least one of the patient report items made a 
significant contribution to the cumulative~. For ex-
ample, the item "How important to you now is treat-
ment for substance abuse?" produced a multiple ~ of 
.30 alone. Thus, the patients' subjective reporta of 
their problema were found to be prominent ill the 
interviewer's estimates of severity. This spin under-
scores the necessity of the clinical aspecta of the 
interview and suaests the importanCe of inclucliDr 
patient reports with objective itema in formulatinl the 
severity estimatee. 
A filial iBlue railed by the uniformly hiP reliability 
ac1'08ll the aD problem scales is the eztent to which 
the problem 8I"e88 are interrelated. If the problem 
ueas and their severity estimates are biPly related 
to each other, then the determiDatioD of one aeverity 
estimate (i.B., subscance abwIe severity) miaht euft a 
controlliDg influence upon the ocher scaIea. tMreby 
accounting for their high reliabilitia In order to de-
termine the nature and excent of the relationshipe 
amoDi the scales, correlation coefticients were calcu-
lated on the ASIs of 524 male veteraD substaDce abuse 
clients (Table 4). AJJ can be aeea, the intercomtlationa 
are generally quite low, with the esceptioD of the 
psychological and family/social scales (.41), iDdic:atinl 
a considerable deane of iDdependence SlDODI the 
scales. This result was much different &om our e .. 
rience with the Health-8icknea Rating Scale, in which 
the components of mental health tended to be hiPlY 
intercorrelated and hichly correlated individually with 
the global ratina (19). As a further test of these rela-
tionships, we performed the same analysis with aeveral 
obvious subgroups of the population. These included 
alcoholics, dna, &delicta, thOle over 46 yean old. thole 
I .. than 46 years old, blacb, and wbices. AlthoUlh 
several small dUfereDC88 ill the iIlternlatiolllbipe of 
these ratinp were noticed between the subpoupe, the 
majority of the coefficients remained quite low. 
The independence of the siz problem areas indicates 
that the treatment problems presented by addicted 
pat~ents ~ not necesaarily related to the severity of 
thear chelDlcalabuse. This result ill particular suaesta 
that the proposed method of analyziq a patient's total 
condition by the severity of his component problema 
is both reasonable and necessary for the development 
of an effective treatment plan. 
Utility of the ASI 
The Addiction Severity Index was developed to 
provide a more comprehensive and effective method 
for analyziq the total complex of problems found in 
the subatance-abusiq patient. It was hoped that 
tbroUlh this method we would be able to differentiate 
patienca on the basis of their treatment needs and 
provide more directed forms of interVention to mon 
homoceneous poups of patients. In order to ...... the 
ctiacriminative ability of the ASI we compared 354 
male veteran alcoholics with 110 male veteran drui 
addicts 8C1'08I the siz scales. The mean values of the 
ASI scales are presented for both groupe in Table 5. 
~ ezpec:ted, the poups were sipificandy different 
with reprd to the severity of the medical problema 
(due to the INater ap, and lonpr period of abuse). 
However, when the severity of the remaining four 
problem areas is considered, there are DO statistically 
lipificnc differenc:es between the two poupa. This 
does not necesaarily suaest that the paUeDts in these 
two poupa are similar, but rather that the eatent of 
variatioD within each poup is poeater than the differ-
enc .. between the poups. In other words. although 
the distinction between alcoholic and drug abuser may 
acc:ouDt ~or ~e v~tion ill lepl and medical prob-
lema, this classification does not appreciably reduce 
withiD-poup variation in the other" treatmeDt prob-
TABLE 5 
ASI StwriIy Rill.: JI..,. Valua {or 464 JI". Vet ... 
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lema. It should be noted that this interpretation is 
consistent with the findinp from our analysis of ASI 
scale intercorrelations (see Table 4), and these two 
resultS combine to suggest that our substance abuse 
population may be composed of several subgroups of _ 
__ patients, each-with a-somewhat different pattern of 
treatmentproblerns. 
As a test of this ~bmty, andaaa means of -
-----lUIS&tiSiiii-tlie utility--ofthe ASI in differentiating pa-
tients into relatively homogeneous subpooups, we per-
formed a cluster analysis on ISO randomly selected 
patients (75 alcohol, 75 drug) using their liz ASI scale 
values aa independent variables. In the particular type 
of cluster analysis selected (4, 16), groups (clusters) of 
patients are formed by minimizing the difference (Eu-
clidean distance) between values on each of the scales 
within the clusters and maximizing the differences in 
mean values of the scales between clusters. Since we 
had no theoretical or mathematical rationale for var-
iable weighting of the scale values, all six were treated 
equally in the analysis. Prior to presentation of the 
results, it should be noted that this method is only one 
type of cluster procedure (11, 16) and will produce 
systematically different results from methods which 
group on the basis of correlations or covariances be-
tween variables. 
The results of this analysis are presented in Table 
6, which shows the resulting six statistically different 
(p < .01) clusters and the mean values for their siz 
problem severity scales. The differences between clus-
ters in the scale severity scores explain in large part 
the low intercorrelations between the scales when the 
data are ungrouped (Table 4). Analyses of scale inter-
correlations within each of these clusters indicate 
rather high (.75 to .90) relationships among three or 
four scales within each cluster. 
The mean severity profiles of the clusters are inter-
esting, since they correspond with several "types" of 
patients which are commonly seen during treatment. 
For example, cluster 4 corresponds to the medical 
model of addiction as a progressive syndrome. The 
average profile for this group is demonstrative of pa-
tients with significant problem severity in all aspects 
of their condition. In contrast, cluster 3 depicts pa-
tients with a high substance abuse severity but few 
additional problems. Cluster 5 is especially notewor-
thy, since the mean profile of this group indicates that 
although substance abulle may be their presenting 
compljUpt it is not their moat severe treatment prob-
lem. 
_In~, the results ohhis cluster BDaljsiS-do 
augest the utility and effectivenesS of the ASI as an 
evaluative method for differentia~_clientsjDto-sub-----
groups"Witlldift'erent pattiriis of treatment problems. 
It is beyond the focus of this paper to pursue in depth 
the rationale and methodololY involved in cluster 
analysis. We have considered several clusteriDI strat-
egies with multiple methods for combining cases, and 
these results will be presented in another paper. It 
should be clear that the particular clusters presented 
here may not be i,ndicative of groups found in other 
clinics, especially programs with adolescents, women. 
nonveterans, etc. However, the data suggest that the 
ASI scales can be effective in differentiating a sub-
stance abuse population into whatever appropriate 
subgroups at. 
Conclusions 
We have attempted to show the need for a stan-
dardized clinical research instrument suitable for gen-
eral use in the study and treatment of substance abuse. 
This instrument should have the capacity to analyze 
the total addiction profile into its component treat-
ment problems, and to estimate reliably and validly 
the severity of each of these problems. Our early 
results with the ASI suggest that it may have the 
potential for being such an instrument. 
Clearly, much work is still required to establish 
further the reliability and validity of the instrument 
with other patient populations and other teams of 
judges. Despite the considerable work remaining, we 
expect that -the ASI should fill the need for an instru-
ment to assist the clinician in integrating and sum-
marizing the background and current status of pa-
tients. In addition. we feel the ASI may be of special 
assistance in determininl a treatment plan for the 
individual client. 
We are also encouraged by d.i!t PQ~l!..tialJ)enefit of-
the ASI to reSearch in the -field of addiction. After 
proper standardization we would hope that the ASI 
would be suitable for general use in clinical research 
and thus facilitate greater comparability of results 
TABLE 6 
ASI fkverity RGtin6s: Allalysis of Patiellt SubtypH in 160 Mak V..".,. &68tanc.-.r.4"- PatiMU (7S .4ko11olic. 7S Dr'u6 Addict«i) 
Cluter N Abule Medical En!pIoymene/Suppon LepI Family/Social P'IIychoIap:aI 
40 6.5 1.5 5.& 3.5 5 2 
2 32 7 2 .. .& 1 5 5.5 
3 27 6 2 2 1.5 1.5 2 
4 25 7 5 6.5 5 6 7 
5 14 5 I 2.5 .. 5.S 6.5 
6 12 5 4.5 2 5 6 5 
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(34). In addition, an instrument such as the ASI may 
permit more effective matchinl of patients ae the start 
of experimental treatments and a more comprebeDBive 
evaluation of post-treatment outcome. 
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APPENDIX B. 
EXPLANATION OF DRUG CLASS 
EXPLANATION OF DRUG CLASS 
1. Heroin: opiate. that is usually intravenously administered. 
2. Program methadone: oral opioia = (synthetic opiate) that is 
administered in mgs doses from government-sponsored c1 inics. 
3. street methadone: the program methadone that finds its way to 
the street. 
~. Cocaine: a nonopioid with analgesic properties. 
154 
5. Po1yopioid: oral and IV administration of synthetic prescription 
opiates such as codeine. d 11 audid. percodan. These may be 
obtained through prescription or through illegal means. 
6. Speedball: a combination of heroin and cocaine administered 
i ntrav enou sl y. 
7. Hits: a combination of codeine and doridian--both having 
analgesic and sedative effects--taken orally. 
APPENDIX Cl 
CONSENT FORM 
.~. " :.! .:.. . ..; ...... . .... '.~ ....... . 
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Pair Oaks Hosoital 
Consent to Participate in a Clinical Research Study 
You are invited to participate In an exploratory study ·which is trying to evaluate the 
• 
success ot our drug abuse program in the treatment ot opiate addicts. While this study 
• 
wm not benetlt you directly in this hospitllization, It may help us improve upon what 
we already know about who benetlts most and who benetlts the least trom our treatment 
· . . 
propm.. ThIs study may help the prosram Improve Itself. By living your consent 
you allow Dr. Gold, Mr. David OCkert, Dr. Extefn· or Dr. Annitto to copy and retain 
I • 
Y9ur pharmacy records, outpatient program attendance and outpatient drug abuse records 
and speak to you by telephone at 3-6 month intervals to find out how you are doing. 
i . 
Your ~rds and all intormatioa ~ut you wm be confidential, ~ed IJIld stored by 
patient niunber and not b)' name. Yo~ consent ·to a video taped~ Addiction Severity 
Interview' CASt) is also requested. Onci this tape is rated· and used in )'Our treatment 
.. . : .. 
by Dr. Annltto and the pI'OII'am It wm be erased. 'nIe tape wID only be saved it )'ou 
request ~t it be retained u part of )'Our medical records in writing prior to POR 
:- .. 
discharge, ·Your consent·· t~ this study 11 voluntary. It JOu decide not to become 
. . 
- involved Ip this study JOur decision wm not effect 8Il)' current or future treatment here 
.... '. a~ POB. • Your name or· ldentifJinr inforniation Win ·not be used in any paper or book 
written about this stud)'. It)'Ou have any additional questions whatsoever about the 
".. . • ""1'.... '. • • . .•. , . 
purpose or nature ot this studJ please .. before siplnr. 
"nle purpose of thls study bas been expla1ned to me. I understand this study 
.,. .... ~.~-.~ give my consent to become involved in ~. study. I have had an op~rtunity to 
.. :-":; ask questions and have had my. questions answered to my satisfaction _or I have no 
..... -. 
questions • 
.. . ____________ Cpatient name) ____________ (date) . 
___________ Cwitness) __________ (.date) 
.. " - ---. --.. - -_.", 
. . 
..• I __ .• _'_ ····.n-




DRUG HISTORY VARIABLES 
PROCESS VARIABLES 
FAIR OAKS HOSPITAL 158 
INTAKE DATA FORM FOR DRUG USERS 
NAME PHONE _______________ AGE 
ADDRESS 
CHART NUMBER: 
1) Age of first drug use 
2) Age of onset of opioid use 
3) Years addicted 
4) Age at first treatment contact 
5) Age at first arrest Charge: Narcotic Non narcotic 
----
6) Pre-induction drug use: 
a. Heroin 




7) Level of use: Frequency per day _ Weekly ... $____ Program meth. ____ mg. 
PROCESS DATA: 
1) Time on clonidine 
-----------------------
Average stabilizing dose (fourth day) 
2) Time on naltrexone 
Number of naltrexone Administrations/DOSF 
-----------------3) Other drugs used ____________________________ _ 
4) Treatment contacts: Family group _______ Multiple family group ______ _ 
APPENDIX C3 




1. Le .... No BI.nks - Where appropriata code 
items: X - quarrion not ans_red 
N - question not applicable 
Use only one ch.racter per item. 
2. Item numbe" printed in rad .ra to be .ked at 
follow·up. Items with. rad arrerisk enr cumu-
lati"" and should be rephrased at follow·up 
lsee Manuall. 













1 - Intake 
2 - Follow·up 
CONTACT CODE: 
1 - In Pe"l>n 














1 - Patient terminated 
2 - PatIent reluled 




I I I 
m 
o 
V.A. ~OR'" 10-. ISUI REVISED SEP'T. '''0 
ADDICTION SEVERITY INDEX 
SEVERITV RATINGS 
The severity retings are intervi_r ani mat .. 
of the pariant', need for additional trearment 
in each araa. Tha seale, range from 0 Ino traat-
mant necessary I to 9 Itrelltmant needed to inter-
... na in lif.-threataning situation). Each raring is 
b •• d upon the Piltiant'l history of problem 
symptom" present condition and subjective 
a.assment of his tI'9.tment needs in a given 
area. For a detailed description of severity 
ratings" derivation procedures lind conventions, 
see manual. 
GENERAL INFORMATION 
NA~IE ________________________________ ___ 
CURRENT ADDRESS _________ _ 
GEOGRAPHIC CO OF OJ 
1. How long ha"" you 
lived at this address? CDI I I 
., ... 
2. II this residence owned by you 
or your f.mily? 
0- No 1 - Ves 
3. DATE OF 
BIRTH 
4. RACE 
1 - White (Not of Hi_nic Originl 
2 - Black INot of Hi_ic Origin I 
3 - American Indian 
4 - AI_ken Nati"" 
5 - Asian or Pacific I.lender 
6 - Hi_nic - Mexican 
7 - Hispanic - Pu~no Rican 
8 - Hispanic - Cuban 
9 - Othar Hispanic 
5. RELIGIOUS PREFERENCE 






6. H .... you been in a controlled en-
vironmenl in Iha p8ft 30 days 7 
1 - No 
2 -Jail 
3 - Ala>hol or Drug Treatment 
4 - Medical Tralltmant 
5 - Psychialric Treetment 













. Third Edition 
SUMMARVOF 
PATlENT·S RATING SCALE 
0- Not ar all 
1 - Slightly 
2 - Moderately 
3 - Considerably 
4 - Extremely 
.rEST RESULTS 















~ .... ..J U 
W c( .... 0 0 
..J ~ :J ::: ..J ~ ::r ID !(! 0 CJ c( U 0 C .... U ;:) CJ ~ > a: w 
" 
.... a: w « ... 





How many limes in your life 
have you been hosollalized .CIJ 
for medIcal problems? 
(Include o.d. 's, d.r. 's, ""elude d"ro".} 
How long ago was YOUmrn 
lasl hospilalizalion for 
a physical problem? " ... 
0'0 you-have any chronic medical 
problems which COntInue to inler· o 
fe", with your life? 
---O-.o.-No- .... '1' - Yes------
4. Are you laking any' prescribed 
medication on a regular baSIS 
for a physical problem? 
o 
'·t. 







0- No 1 - Yes 
Education completed OJ CD 
fGED = 12 years} Z' 
Training or technical ".... CIJIIO .. 
education compleled .D •. 
Do you have. profession, 
trade or skill 7 
O-No 
1 - Yes ___ .,.,-____ _ 
Specify 
Do you have • ".Iid driver'S 
license 7 
O-No 1 - Yes 
Do you have an aUlomobile 
lIYailable for your use? (Answe, 
No if no "alid d,i.,.,'slicense./ 




How long was your OJ CIJ 
longen full·time lOb? 
...... . ... 
Usual lor last I occupation. D 
(Specify in der.,t} 
Does someone contribute 10 your 0 support in any way' 
0- No 1 - 'fes 
lor~LY IF ITEM 8 IS YES) 
Does this conSlllute the majority 0 of your support? 




Do you rwcai ... a .-nsion for a 





How many days h_ you OJ 
experienced medical . ---. - . ' ,-
problems in the pall 30? 
., 
9. 
How important to you now is 
".atment for these medical 
probleml? 
161 
INTERVIEWER SEVERITY RATING 
How would you rate the patient's 
nlld for medical treatment? 
CQNFIOEN~E RATINq~_ 
II the above information signifi-
D 
D 
FOR OUESTIONS 1 &" iF;'L'EASE ASK PA tiEivT 
TO USE THE PA TIENT'S RA TlNG SCALE. 
·1 ___ ~ca=n.!'y_c;llS~!l."jld.l;I.v'~: ___ _ 
D 
7, How troubled or bothered have 
you been by these medicel 
problems in the pan 30 days? 
COMMENTS 
IMPbQYMEtliT llYPPQBT STAIYS 
10 Usual employmenl pmern, 
pan 3 years. 
1 - full lime 140 nrslwkl 
2 - part time lrev. hrsl 
3 - part time lirrev., davworkl 
4 - nudent 
5 - lervice 
• - retired/disability 
7 - unemployed 
8 - in controllad environment 
o 
0 
11 How many daYI _re yOu paid []] for working in the past 301 
flnt:lu. "un., rhe reble" worlr./ 
How 
ing 
much money did YCIII receive from the follow-
sourcas in the pan 30 daYl7 
Employment I I I I (n,t int:omel 12 
Unemployment I I I I com.-n .. tion 13 
14 CPA I I I I 
5. Pension, benefin I I I I or SOCial security 
6. Mate, family or I I I I friends (Mo""y fo, 
Pflrsonal e.pensesl. 
7. III .... I I I I I' 
COMMENTS 
10. Patient'S misrepresentation? 
0- No 1 - Yes 
11. Patient's inability to understand7 
0- No 1 - Yes 
1S. How manY,D9Qple depend on 
you for the majorilV of their 
food, shelter, etc. ? 
19. How many dayl have you 
experienced employment 
problems in the pm 307 
D· 
FOR OUESTIONS 19 & 20 PLEASE ASK PA· 
TlENT TO USE THE PA TIENT'S RA TING SCALE 
20. How troubled or bothered h_ 
you been by the .. employment 
problams in the past 30 days? 
21. How important to you now il 




INTERVIEWER SEVERITY RATING 
22. How would you rata the patient's 
need for employment counseling? 
CONFIDENCE RATINGS 
lithe above information signifi-
cantly dislorted by: 
23. Patient'S misrepresentation? 
O-No 1 - Yes 
24. Patient's inability to understand? 




CARD [2J 10 
1.0. ,r---rTJ ~ 
CODE # 
.01 • Alcohol· Any 
use at all 




• Other opiatesl 
analgesics 
· Barbiturates 







• 12 • Inhalants 
PAST :10 
DAY. 





Note: See manual 
for each dru 
for representative examples 
9 class. 
:[[]I .,3 • More than on subst ance per day (Incl. 
"'coho/I. ...... 
I I I 





14. Which sutmence il the meior 
problem 7 (,.,... codtt _ 
MID"" or DO·No problem; 
15·Alcohol & Drug [Dual 
addiction! ; 16'Polydrug; 
whIm no, cl .. r, /lilt pa,i"", •. 
15. How long _I your last 
period of voluntary 
abstinence from this 
major substance? 
(00 . n."., .bsrinllnr I. 
16. How many months ago 
did this abstinence end? 
(00 . nil/aM,in"nr/. 
• 1 7. How many time. have you: 
Had alcohol d.t:. 
Overdosed on drugs EB 
.'8. How many time. in your life h_ you 
been treated for: 
Alcohol Abuse 
Drug Abuse EB 
• 19. How many of th ... _nt «Ietox only? 
Alcohol 
Drug EE 
20. How much would you say you IPInt during 
the past 30 days on: 
Dru ... I I I I I AlcohOl 
COMMENTS 
162 
21, How many day. h_ y- been I 
tntated in en outpatient set· L_...L._...I 
ting for alcohol or d",p in the 
Plat 30 days? {/nclut* NA, AAI . 
22. How many days in the past 30 
have yOU experienced: 
Alcohol Probl"ms 
Drug Problams EE 
FOR OUESTIONS 23 & 24 "LEASE ASK PA· 
TIENT TO USE THE PA TIENT'S RA TlNG SCALE 
23. How troubled or bothered have you been in 
the p.t 30 days by these: 
Alcohol Problems 8 Drug Problems 
24. How important to you now is treatment for 
the .. : 
Alcohol Problems B Drug Problems 
INTERVIEWER SEVERITY RATING 





Is the above information lignifi· 
cantly distorted by: 
26. Patient's misrepresentation? 
O-No 1 - Ves 
G 
27. Patient'S inability to understand? 
D 
SDD O-No 1- Yes 
CARD mao 
1.0. .IL--..J-..I -1-1 --1...1---11 
1. 
2. 
W. this admission prompted 
or suggeRIId by the criminal 
justice system Ijudge, prObationl 
parole officer, atc.l7 
0- No I-V" 
Are you on probation or 
parole 7 
-
0- No I -Vas 
How many times in your lif. h_ you been 
D 
D 
_. . _________ .a.rested.and.charged·with-the·following criminal 
offenses: 
.COOE :t 
* 03 - shoplifting/vandahsm 
0 04 - parole/probation violations 
* 05 - drug charges 
• 06 - lorgery 
• 07 - weapons offense 
• 08 - burglarv, larcenv, 8 & E 
* 09 - robbery 
• 10 - assault 
• 11 - arson 
* 12 - rape 
• 13 - homicide, manslaughter 
·,4 - other 
LEGAL STATUS 
* 15. How many of th ... charglll 
r8Ultld in convictions? OJ 
How many lim. in your lif. h_ you bean 
charglld with Ilia following.: 
a'6, Oilordarly conduct, vagrancy, 
public intoxiClllion 
*n. Driving whita intoxicated 
*'8. Majorai'ivingvioliriioril---
(rackle .. driving, spaldinll, . 
no licen .. , atC,). 
*19. How many months wa .. you 




21, What was it for7 
(Ulle codtl3· '4, '6·'8. 
22. Ara you p .... ntly awaiting 
charglll, trial or .. ntance ? 
O-No 1- Yel 
23. What for? (if mulripltl 
choice, u .. mort _nlJ. 
24. How many days in tha past 30 













25, How many dayl in Iha pan 30 I I I 
haw you angaged in iIIegel l... _.L __ ~_ 
_lviti. for profit? 
FOR OUESTIONS 26 & 27 PLEASE ASIC PA-
TIENT TO USE THE PA TIENT'S RA TING SCALE 
26: How'serious'do'You faal'your 
present legal problems a .. 7 
(Elfcludtl cillil probltlmllJ 
D 
--------------------27, How imponant to you now is 0 
coun .. ling·or ref.rral for th_ . 
I ..... prOblams 7 
INTERVIEWER SEVERITV RATING 
28. How would you rata the patient'l 0 
need for legal I.rvices or counseling? L 
29, 
CONFiDENCE RATINGS 
II the above infonnation signifi· 
_tly diRoned by: 
Patient's misrep_entation? 
O-No 1- VIS 
30. Pltient's inapi/ity to understand? 












.0 1 - Married 4 - Separatad 
2 - Remarried 5 - DillOrnd 
3 -Widowed 6 - N_r Married 
How long h_ mm you been in 
this marital statu. 7 • ., ... MO •• 
{If n..,., marriN. $inc. aga 18J. 
Are you satisfied with this situation 7 
O-No 
1 - Indifferant 
2- Yes 
Usual living arrangements (past 3 yr.l 
1 - With sexual partner 
and child.,," 
2 - With sexual partner alone 
3 - With parenls 
4 - With family 
5 - With friends 
6- Alone 
7 - Controlled environment 
8 - No stable arrangements 
o 
D 
How long haY\! m rn 
you liY\!d in 
these arrangements. "... 110 •• 
(If wirh PII"mr. 0' ,."il'l. 
.inc. ... 18J. 
Are YOU satisfied with th_ living 
errenlllments 7 
O-No 
1 - Indifferent 
2-V • 
D 
FAMIL YISOCIAL RELATIONSHips 
7. With whom do you spend most of 
your fr .. time: 
1 - Family 
2 - Friends 
3 - Alone 
~ 
8. Ara you .. tisfied with spending 
your frea time this _y7 
O-No 2-V .. 
, - Indifferent 
9. How many cION frie~ do 
you have7 -r'.l~' 
, O. How many day. in Ihe past 30 
have you had .rious conflicts: 
A. with your family? 







Have you had significant periods in which you 
h_ experienced ~ problem. with: 




·'4. Sexual pannerlspouse 
·'5. Children 
:·'6. Other significant family _____ _ 
.". Closa friends 





How many times have you b .. n treated for 
any psychological or emotional problems 7 
In a haspilal CD 
A. an Opt. or Priv. parienl I IT] 
Do you receive a pansion for a 
psychialric disability? 
0- No , - Ves 
D 
Have you had a significanl period, /thel was not 










anxiety or tension 
Experienced hallucinations 
Experianoad tfOUbII Uftdw· 
standing. co_tratlnll or 
_mbering 
Experienced lrouble control· 
ling viOl em behavior 
Experienced serious 
thoughts of suicide 
Anempled suicide 
* 10. Have you taken prescribed 
medica! ion for any psvcho-
logical/emolional problem 
'01 
......... _ YOU_ 
DA ........... . 
PSYCHOLOGICAL STATUS 
, ,. How many days in Ihe p_ 30 
have you experienced these 
psychological or amotional 
problems? 
FOR OUESTIONS '2. "PLEASE ASK PA· 
TIENT TO USE THE PA TIENn RA TING SCALE 
, 2. How much h ..... you been troubled 
or bothered by th_ psychologicel 
or emolional problem. in Ihe p_t 
30dayl7 
13. How impananlto you no ... i. 




THE FOllOWING ITEMS ARE TO 8E 
COMPLETED BY THE INTERVIEWER 
AI the lima of this interview, i. plllient: 
O-No 1- Ve. 
I.. Obvioully depreaad/withdrawn 0 
15. Obviously hostile D 
16. Obviously IIIxiou./nervou. D 
17. Havinll trouble with reelity lilting. D 
thought disorctars. ~id thinking 
164 
. FOR OUESTIONS 20·23 PLEASE ASK PATIENT 
TO USE THE PA TIENT'S RA TING SCALE 
How troubled or bothered have you b .. n in the 
p_ 30 days by these: • 
B 20. Family probleml? 21. Social problems7 
How important to you now i. traatment or 
counselinll for thase: 
22. Family problems? 
23. Social problems? B 
INTERVIEWER SEVERITV RATING 
24. How would you ra,. the patient's 




lithe above information ligni ficantly 
distorted by: 
25. Patient'l misrepresentation 




18. Havinll trouble comprehending. D concentrating. remembering 
19. Heve suicidal thoughts D 
INTERVIEWER SEVER lTV RATING 
20. How would you rille the patient's 0 need for psychiatric/Plychological 
treatment? 
CONFIDENCE RATINGS 
Is Ihe above information .ignifi. 
cantly distorted by: 
21. Palient's misrepresentation? 0 0- No 1-Vas 




.. -._-_ ... _-
APPENDIX C·4 
NATURAL SUPPORT SYSTEMS MATRIX 
Natural Support System 166 
Conjugal 




Cheer You Up 
hae 'Ti1D! 
Companion 
Takes Care of 
You When Sick 
Continuous Proximity 





























BRIEF PSYCHIATRIC RATING SCALE 
Form 
168 
FAIR OAKS HOSPITAL 
BRIEF PSYCHIATRIC RATING SCALE 
Patient Name ________________________ _ Rater Name ____________________ __ 
Date Time 
NOT VERY MODER- MODER- EXTREMELY 
PRESENT MILD MILD ATE ATELY SEVERE SEVERE 
SEVERE 
I. Somatic Concern 1 2 3 4 5 6 7 
2. Anxiety 1 2 3 4 5 6 7 
3. Emotional Withdrawal 1 2 3 4 5 6 7 
4. COnceptual Disorqanization 1 2 3 4 5 6 7 
5. Guilt feeling 1 2 3 4 5 6 7 
6. Tension 1 2 3 4 5 6 7 
7. Mannerisms & Posturing 1 2 3 4 5 6 7 
8. Grandiosity 1 2 3 4 5 6 7 
9. Depressive Mood 1 2 3 4 5 6 7 
10. Hostility 1 2 3 4 5 6 7 
lI. Suspiciousness 1 2 3 4 5 6 7 
12. Hallucinatory Behavior 1 2 3 4 5 6 7 
13. Motor Retardation "1 2 3 4 5 6 7 
(Slowed Movement) 
14. Uncooperativeness with I 1 2 3 4 5 6 7 
15. Unusual Thought Content 1 2 3 4 5 6 7 
16. Blunted Affect 1 2 3 4 5 6 7 
17. Excitement 1 2 3 4 5 6 7 




BECK DEPRESSION INVENTORY 
.' 
• 
" F:\LKlm~ !/(iSPI"l'AL !. 
SECK DEPRESSIC~I I:'I'!E~IT(jnY (SD!) 
170 
Cl.cirt !" .iar.:e ___________ ., ........ _....__-__ !late ______ ---
nn this 'luestionnair~ are "crroups of statements. Please read. each (!ro~" 
o'f state..'1'1ents carefully. Then pick out the one state~ent in e~ch arour, ~'/~ich 
. best descri bes the "/a.v yOU have been feel ina thf! !lAST !JE!;,'~, T"~Lrrnp,r, T"I"\~V ~ 
eirc1 e the number beside the statement VOIl oicked. II se'lera 1 s~atp.f.1errts 
in the "rouo see~ to aOr.'ly equally "/ell, circle each one~ 
Poe sure to read all th~ statements in each orouo before makinn your choice. 
1. n I do' not feel sad. 
1 I feel sad. 
2 I am sad all the time and I can't snao out of it. 
3 I am so sad OT" unha!JPY ~hat ! can't stand it. 
2. n r am not narticularly discouraaed about the future. 
1 I feel discouraced about the future. 
2 I feel I have nothina to look fO~/ard to. 
3 I feel that the future 1s hopeless and that thincs cannot imorove •. 
3. n r do not feel like a failure. 
-
1 I feel I have failed more than the averaae nerson. 
2 .~s I look back on my life, all I can see is a lot of failures. 
3 r feel I am a comp1ete failure as a cerson. 
. . 
n I cet as much satisfaction out of thinos as r used to. 
1 r don't enjoy thinas the way I used to~ 
2 r don't ('let real satisfaction out of anythinn ·an'lTilore. 
3 I am bored or dissatisfied ''lith everyth·ina. 
5. 0 I don't feel narticularly auiltv. 
1 I feel cui 1 tva' aood part of the tif'1e. 
2 I feel tlUite auilty .TlOst of the time. 
3 I feel ~u i1 tv all of the time. 
6. () I don't· feel I am befno punished. 
1 I feel I mav be punished. . 
2 I exnect to be ounished. 
3 I feel I am beina punished. 
7. 0 I don1t feel disaopointed in myself. 
1 I am di~aopointed in myself. 
3. 
. ' 
2 r am disausted \'I1th myself. 
3 I hate myseif. 
n I donlt feel I am any worse than anybcdv else. 
1 I am critical of mys'elf for mv weaknesses or mis:akes. 
2 I blame myself all the time for my faults. . 
3 I blame myself for everythina bad that haooens . 
••••••• I 
.'-
"l .. !"; .! don't have at1'l thouchts C7 kiliinn :nvse,!f.· 
1 I have thou~hts of !dllino myself, but! It/Quid 
2 I , .. /ould 11 ke to ki 11 r,l'Iself. . . 
not carry the~ out. 
:'3 r \·/ould kill II1Vself if I had the chance. 
In. n I don't cry anymore than usual. 
1 I cry mare now than ~ used to. 
11. 
-2 r cry an- the time nO\'I. . 
3 r used to be able to Cry, but now I can't cry even thouOM ! want to. 
n r am no mare irritated now than r ever am. 
1 r oet annoyed or irritated more easily t~an r'~':.'ied to. 
2 r feel irritated all the time- now. 
3 r don't Qet· irritated at all by the thinas that used to irritate me. 
12~ 0 I have not lost interest in other people. 
1 r am less interested in other Deonle than I used to be. 
2 I have lost most of my interest in other people. 
3 I have lost all of my interest in othar people. 
13~ 0 r make decisions about as well as I ever could. 
1 I Dut .. off makina decisions more than I used to. 
2 r have ~reater-d1fficulty in mak1n~ decisions than before. 
3 I can't make decisions at all an.ymore~ 
14. 0 I don't .feel r look any worse than I used to. 
1 I am worried that I am looking old or unattractive. 
2 I feel that there are oermanent chanaes in my aDDearance that make 
me look unattractive. . .. . 
3 I believe that r look ualy. 
J 5 • 0 I can worle about as ~Ie 11 as before. 
1 It takes an extra effort to oet started at doinq somethin~. 
2 I have to push myself very hard to do anythin~. 
3 I can't do any work at all. 
] 6. (') I can sl eep as \'1ell as usual. 
1 I don't sleeo as well as I used··to·. 
2 I wake uDl-2 hours earHer thart· usual Lnd ~ind it hard to net back 
to sleep·. 
3 I wake UD several hours earlier than I used to and cannot oet back 
to slee~·. 
17. a I don't oet more tired than usual. 
18. 
1 I /let tired more easily than -r used to. 
2 r oet tired from doinq almost anythino. 
3 I am too tired to do anythinq. 
n ~v a~Detite is no worse than usual. 
, ~~·Y aopetite .; s not as ~ood as ; t used. to be. 
2 :"y aopet1 te is much \%rSf!. nO\,I. . 







l"~. n I haven't lost much weioht, if any lat~l~. 
1 I have lost more than 5 oounds. " 
2 r have lost ~ore than 10 pounds. 
3 I have lost more than 15 ooun~s. 
I am purposely tr.Yi.n~ to lose weioht by eatin!] less. 
172 
Yes No 
20. a r am no more worried about my health than usual. 
1 I am \'iOrried about physical problems such as aches and oains; or 
upset stomach; or constipation • 
2 I am very \'torried about physical prohlems ari"d it's hard to think 
of much else. 
3 I am so worried about my physical problems, that r can.not think aholit 
anythino else. 
21. a I have not noticed any recent chan~e in my interest in sex. 
1 I am less interested in sex than r used t~ be. 
2 I am much 1 ess interested in sex nO\'I. 
3 I have lost interest in sex comoletely. 
" 
PAXIENT'S SI~~~ ____________ ~ ________________ _ 
"iCDRE 
---------
:1 .. 
